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ABSTRACT 
High fat diet (HFD) consumption in rodents alters body composition and weakens 
bones. Whether female offspring of mothers consuming a HFD are similarly affected at 
weaning and early adulthood is unclear. This research determined whether maternal HFD 
contributes to long-lasting alterations in body composition and bone health of female 
offspring. Rats were fed control or HFD for 10 weeks prior to and throughout pregnancy 
and lactation. Female offspring were studied at weaning or 3 months of age (consumed 
control diet). Main findings in female offspring: maternal HFD decreased lean mass, 
increased fat mass and femoral BMD at weaning, but not at 3 months; weanling femoral 
lipid composition reflected maternal diet, persisting to 3 months of age (decreased total 
and n6 polyunsaturates, increased saturates); and no differences in femoral strength at 3 
months. In summary, 3 month old female offspring have similar body composition and 
bone health regardless of maternal diet. 
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Chapter 1.0: Introduction 
1.1. Osteoporosis in Canada 
Osteoporosis is a disease in which bones have become weakened through gradual 
loss of mineral and structural integrity, leaving bones fragile and more susceptible to 
fragility fracture. The incidence of osteoporotic fracture in Canada is among the highest 
in the world, ranked in the top quarter internationally [1]. According to the 2009 
Canadian Community Health Survey conducted by the Public Health Agency of Canada, 
the incidence of osteoporosis was reported at 1.5 million or 10% of Canadian adults 40 
years or older [2]. Osteoporosis Canada reported that the incidence of osteoporotic 
fractures is greater than the  incidence of breast cancer, heart attack and stroke combined 
[1]. Once an individual has suffered from an osteoporotic fracture they are at an increased 
risk of additional fractures. The prognosis for recovery from major osteoporotic fractures 
is grave; with hip and vertebral fractures being the most severe. Approximately 28% of 
Canadian women and 37% of men who suffer from hip or vertebral fractures will die 
within a year [1]. It is therefore of utmost importance for Canadians to develop 
prevention strategies that improve quality of life by reducing the incidence of fragility 
fractures, as well as mortality due to osteoporosis.  
Some purport that osteoporosis is a ‘a pediatric disease with geriatric 
consequences’ [3]. The quantity of bone acquired by late adulthood is dependent on the 
amount of bone gained during childhood and adolescence. Optimal bone mass in 
adolescence can be achieved if an individual achieves their peak bone mass, which is the 
genetically predisposed limit of bone mass one can possibly attain [4]. The amount of 
bone accrued during childhood and adolescence will determine the amount of bone mass 
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one has in adulthood; where individuals who have reached peak bone mass are likely to 
have higher bone mass in adulthood [5]. Therefore, if peak bone mass is not achieved, 
there is a greater risk of developing osteoporosis-related fractures in the future, as bone 
loss with aging is inevitable. For instance, it has been shown that only a 10% increase in 
peak bone mass can reduce the incidence of hip fractures by thirty percent [6]. The 
attainment of peak bone mass occurs in early adulthood, which is depicted in Figure 1. 
Genetics contributes to approximately 60-80% of peak bone mass, however other 
lifestyle factors such as nutrition can alter the predisposed limit [7]. Figure 1 displays a  
 
Figure 1. Schematic of the role of nutrition on peak bone mass and fracture risk  
schematic of the role nutrition plays on peak bone mass. Overnutrition (e.g. high energy 
intake, inadequate nutrient consumption), represented by long hashed lines, can lower 
peak bone mass, and subsequently increase the risk of fragility fracture earlier in life. 
Optimal nutrition with adequate intake of important nutrients that support bone health 
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(e.g. calcium and vitamin D), represented by short hashed lines, may lead to a higher 
peak bone mass, and thereby delay the risk of fracture until later in life. It is therefore of 
considerable importance to understand how certain modifiable lifestyle factors such as 
diet can help improve peak bone mass development and promote overall bone health. 
Furthermore, whether specific nutrients can influence peak bone mass should be 
investigated further, especially considering the high incidence of osteoporosis and 
increased mortality associated with fragility fractures.  
 
1.2. Bone development and growth  
1.2.1. Bone development 
 Bone development begins in utero by two processes known as intramembranous 
and endochondral ossification [8, 9]. Intramembranous ossification is responsible for 
formation of the skull and facial bones [10]. It begins with the formation of limb buds, an 
accumulation of mesenchymal stem cells, which is controlled by many genes, particularly 
the Hox family genes [11].  Mesenchymal stem cells become condensed and highly 
vascularized [9], and differentiate to osteoprogenitor cells by transcription factor Runx2 
[11, 12]. Eventually these osteoprogenitor cells further differentiate to osteoblasts by 
osterix, and express Runx2 and type I collagen. These osteoblasts can then excrete 
osteoid matrix that later becomes mineralized [12]. Osteoblasts either succumb to 
apoptosis or become mature osteocytes that remain embedded in the bone matrix [12]. 
The mineralized osteoid matrix forms bone spicules that later help form the lamellae of 
the Haversian canals [9]. 
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Endochondral ossification is responsible for bone formation in the majority of the 
skeleton [10], particularly long bones, while vertebral and pelvic bone formation is a 
product of the combination of intramembranous and endochondral ossification [11]. The 
main difference between intramembranous and endochondral ossification is the fate of 
mesenchymal stem cells. In intramembranous ossification, mesenchymal stem cells 
differentiate directly to bone, whereas mesenchymal stem cells in endochondral 
ossification differentiate to cartilage, which acts as a template for future bone growth 
[12]. Long bone formation is initiated with the connection and condensation of 
mesenchymal stem cells that subsequently become loose mesenchyme, coordinated by 
the transcription factor Sox9 [11]. This forms the limb bud or initial template for further 
bone formation [12].  Sox9 also initiates the differentiation of condensed mesenchymal 
stem cells to chondrocytes [10, 11], that begin to lay down a cartilage matrix composed 
of type II collagen [12, 13]. Chondrocytes further mature and proliferate to hypertrophic 
cartilage, exiting the cell cycle, and secrete extracellular matrix that expresses collagen X 
[13] instead of type II collagen in the cartilage matrix [12]. Hypertrophic chondrocytes 
secrete factors to promote angiogenesis, which subsequently promotes transportation of 
osteoblasts and osteoclasts, as well as hematopoietic cells to cartilage [13]. The addition 
of these cells helps create primary ossification centres to allow for bone formation to 
occur. At this site, the hypertrophic chondrocytes undergo apoptosis, and osteoblasts help 
to build bone after increasing accumulation of calcium and enzymes such as 
metalloproteinase and alkaline phosphatase to promote mineralization [11].  
 The primary ossification centres of long bones begin in the diaphysis, and with 
the proliferation of chondrocytes, the epiphyses begin to form at the end of long bones. 
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These chondrocytes undergo hypertrophy and eventually undergo apoptosis, which 
provides a template for new trabecular bone to be formed [12]. The periosteum begins to 
form at the periphery through intramembranous ossification from the middle of the 
diaphysis towards the epiphysis [14]. The periosteum is composed of an outer layer of 
chondrocytes and an inner layer of osteoprogenitor cells that eventually differentiate to 
osteoblasts, and finally mature osteocytes [12, 14]. At the newly formed epiphyses, 
cartilage canals develop with vascularization. This allows for a mass of chondrocytes that 
begin to hypertrophy at the centre of the epiphysis, which will become the epiphyseal 
growth plate. This occurrence also initiates the formation of the secondary ossification 
centre [14].  
 Bone formation occurring at the secondary ossification centre occurs postnatally, 
after the primary ossification centres have been formed in utero. New vascularization 
occurs, which brings preosteoblasts and mesenchymal stem cells to the ossification 
centre. The previously formed matrix that is proximal to the hypertrophied chondrocytes 
also becomes mineralized at this time. The previously formed cartilage in the epiphysis 
becomes replaced by hematopoietic cells and the secondary ossification centre as it 
continues to grow [14]. The remaining cartilage at the epiphysis goes through its final 
stages of ossification and becomes bone, also known as the growth plate. At this time, fat 
is present in the secondary ossification centre. Blood vessels from the marrow of the 
secondary ossification centre begin to spread to the growth plate and physis (proximal to 
growth plate). Finally, in the last stages of endochondral ossification, the hematopoietic 
marrow turns into fat [14].  
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Bone formation and mineral accretion (calcium, phosphorus, magnesium) is at its 
greatest in the third trimester, however these processes remain highly active in early 
infancy as well. This rate remains high for the first months of infancy, but slows with age 
[15]. Mineral accretion due to delivery from mother’s milk is important in infancy as it 
supports optimal bone and somatic growth. Bone formation remains rapid during 
childhood and adolescence, particularly long bone appositional growth. This growth 
occurs at a fast rate until peak bone mass is attained. At this point in life (early 
adulthood), bone formation is considerably slower, and bone remodelling takes over [16]. 
Bone is continuously remodelled through the coupling of bone formation and bone 
resorption throughout adulthood, which will be discussed further in section 1.2.2. 
Maternal nutrition may also augment offspring bone development, as offspring 
are still being nourished from their mothers in critical and rapid periods (in utero and 
suckling) of bone growth and development. It has been shown that the composition of 
mother’s diet reflects the nutrient composition of the milk [17, 18]. Therefore, maternal 
diet will determine the composition of nutrients being delivered to offspring, which may 
have the potential to augment offspring bone development. For instance, female Wistar 
rats fed a diet restricted in protein had offspring with lower bone mineral density [19]. 
Furthermore, mothers with insufficient (11-20 µg/L) or deficient (<11 µg/L) levels of 
vitamin D during late pregnancy were more likely to have children with lower whole 
body and lumbar spine bone mineral density at 9 years of age [20]. In a society with an 
abundance of food availability and high prevalence of obesity, it is of concern whether 
over-nutrition or increased consumption of a particular nutrient (i.e. elevated levels of 
dietary fat) can augment or impair bone development when exposure occurs in utero and 
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during suckling. This concept of maternal nutrition and offspring bone health will be 
explored further in section 3.2. 
 
 1.2.2. Bone remodelling 
 Bone remodelling is a dynamic process in which bone formation and bone 
resorption are tightly coupled and regulated. The balance between the rate of bone 
formation and bone resorption govern overall bone homeostasis. For instance, a faster 
rate of bone formation compared to resorption will favour bone growth. The rates of bone 
formation and resorption are dictated primarily by the action and number of osteoblasts 
and osteoclasts [21], which originate from bone marrow. Osteoblasts are mononuclear 
cells derived from mesenchymal stem cells, as mentioned in section 1.2.1. Mesenchymal 
stem cells (MSCs) become preosteoblasts through the presence of Runx2 or Cbfa1 [22, 
23], and again differentiate to functional osteoblasts through osterix [23]. Adipocytes are 
also differentiated from these pluripotent MSCs, and the presence or absence of certain 
transcription factors (e.g. PPARγ) may shift differentiation of the MSC to favour 
osteogenesis or adipogenesis during development [24]. The primary role of osteoblasts is 
to regulate bone formation, both by depositing matrix that becomes mineralized and by 
limiting resorption. Osteoblasts secrete bone matrix, more specifically collagenous and 
non-collagenous proteins. Typically, bone is composed of ~90% type I collagen, which is 
important structurally as it provides the template for further bone deposition and 
formation [25].  
Unlike osteoblasts, osteoclasts are multinucleated macrophage-type cells that 
differentiate from hematopoietic stem cells [26, 27]. Growth factor colony stimulating 
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factor, or macrophage colony-stimulating factor secreted by osteoblasts, turns the 
hematopoietic stem cells to preosteoclasts. Preosteoclasts then associate directly with the 
osteoblast cell through its receptor activator of nuclear factor- κB (RANK), and attaches 
itself to the RANK-ligand (RANKL) presented on the osteoblast membrane. This binding 
promotes osteoclastogenesis and furthermore osteoclast apoptosis [28]. Osteoclasts 
become activated through binding of RANKL to RANK, which allows osteoclasts to 
proliferate, develop a ruffled border, and polarize. Once polarized, osteoclasts are able to 
attach to the lining of old bone, and release acids and proteases (e.g. matrix 
metalloproteinase 9 [29]) that breakdown bone [30].  
The rate of osteoclastogenesis is regulated by osteoblasts, through the production 
of a decoy receptor osteoprotegrin (OPG) [27, 31]. RANKL will bind to OPG, thereby 
preventing binding to RANK and subsequent differentiation of preosteoclasts, lowering 
the rate of osteoclastogenesis and subsequently bone resorption. Furthermore, the number 
of OPG present can vary according to the presence or absence of certain factors. For 
example, the addition of estrogen to human osteoblasts in vitro causes increased gene and 
protein expression of OPG [32]. Therefore greater expression of OPG increases the 
likelihood of RANKL to bind, subsequently reducing osteoclast maturation and 
resorption. 
The process of bone remodelling occurs constantly over the lifespan, and can vary 
according to age. In childhood and adolescence, a period of rapid growth, bone 
remodelling will favour bone formation rather than resorption, resulting in bone growth 
and acquisition. However at early adulthood, once peak bone mass has been attained, 
bone formation and bone resorption become coupled, resulting in a net loss and gain of 
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bone. Aging causes bone remodelling to favour bone resorption over formation, resulting 
in bone loss that can lead to the development of osteoporosis. 
 
1.3. Diet, obesity, and inflammation in Canada 
The typical Canadian diet, or Western diet, is comprised of higher than 
recommended intakes of fat, specifically saturated fat [33], and refined sugars. There is 
no particular recommendation on the level of saturated fat one should obtain in their diet, 
as high saturated fat intake is associated with the development of cardiovascular 
disease[34]. However, Health Canada recommends consuming minimal amounts of 
saturated fat in a nutritious balanced diet. The Canada Food Guide outlines the suggested 
servings per day of food groups that contain essential nutrients to support a healthy 
lifestyle (i.e. fruits and vegetables, meat and alternatives). By following the Canada Food 
Guide, an individual would consume only 5.8-7.2% of their daily energy intake from 
saturated fat [34]. However, based on the Canada Community Health Survey, the mean 
daily energy intake of saturated fat is ~10% for Canadian adults, which is higher than 
what one would consume eating a nutritious diet and following the Canada Food Guide. 
Furthermore in Canada, 23% of females and 25% of males have total dietary fat 
consumption above the Acceptable Macronutrient Distributable Range [35] (amount of 
nutrient acceptable for consumption that will not lead to the development of disease 
[36]). Although regularly consuming a diet high in saturated fat is known to be associated 
with cardiovascular disease development, the effect on bone health in humans is not as 
well defined. This novel association may be important to investigate considering the high 
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mortality rate after an osteoporotic fracture [1], and the increased consumption of dietary 
fat in Canada. 
The role of dietary saturated fat on the achievement of peak bone mass and 
maintenance of bone health is not well investigated in humans. Some studies have 
reported increased incidence of fractures in overweight and obese children [37, 38], 
however it is difficult to determine whether dietary fat, sugar, or the combination of both 
can be attributed to these observations. Since diet during childhood and adolescence can 
partly determine peak bone mass [4], it is important to investigate whether higher dietary 
saturated fat intake during this life stage leads to a predisposition of osteoporosis in 
adulthood. 
Although the relative contribution of dietary saturated fat consumption in 
childhood to the risk of developing osteoporosis is not well characterized, it is well 
known that a diet rich in saturated fats can lead to other health complications [33]. A diet 
high in saturated fat may lead to weight gain and subsequent changes in body 
composition. Body composition can be monitored by measuring the ratio of lean and fat 
mass, with a lower ratio being more favourable for mortality [39]. Further monitoring of 
body fat distribution is an important indicator of risk of disease development and relative 
morbidity. Individuals with greater fat mass in the abdomen (visceral fat) are at increased 
risk of developing chronic diseases [40]. Although a diet high in saturated fat may not 
directly cause abdominal obesity, greater caloric intake along with a sedentary lifestyle 
can lead to weight gain, when considering the typical Canadian diet [41]. Since adipose 
tissue is considered an endocrine organ, the levels of circulating hormones released by 
the adipose tissue can also be altered when the quantity of fat mass is altered. For 
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example, the increased release of some pro-inflammatory cytokines is associated with 
chronic inflammation, often observed in obesity [42].  
Because evidence from population studies are limited in terms of the direct impact 
of dietary saturated fats on bone health and body composition and its relative contribution 
to disease development with high consumption, animal models are useful to elucidate 
how a diet high in saturated fat modulates bone health and body composition. The role of 
a high saturated fat diet on body composition, as well as bone health and hormones 
contributing to overall health in animal models will be discussed further in chapter 2.0.  
 
Chapter 2.0: High fat diet consumption 
2.1. Effect of high fat diet consumption on rodent body composition 
A diet high in saturated fat can contribute to elevated body weight [43] and 
greater fat mass in rodents [44], which, when occurring in humans, is associated with a 
higher risk of mortality [39]. The distribution of fat mass, or where fat accumulation is 
greatest, is a more accurate predictor of disease development and health status than body 
weight and fat mass alone. In humans, it is well known that greater fat accumulation in 
the abdomen increases the risk of developing chronic diseases associated with metabolic 
syndrome [45], as well as cardiovascular disease [46]. A common tool for determining 
the degree of abdominal adiposity is by measuring waist circumference in humans [45, 
47]. Animal models are commonly used for high fat feeding and obesity studies, with 
certain well-established models being the most appropriate. Rodent models, such as 
certain strains of mice (i.e. C57BL/6) and rats (i.e. Wistar, Sprague Dawley) are best 
suited for this as they are more likely to become obese and develop associated 
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comorbidities (e.g. insulin resistance) when fed a high fat diet [48]. Studies using these 
models can provide greater insight into the potential role of dietary fat, fat mass 
distribution and disease development. Since a diet high in saturated fat may elicit 
elevations in fat mass, it is likely that abdominal fat mass will also increase, increasing 
the risk of developing and dying prematurely from a chronic disease. 
Another common tool for determining body composition in both humans and 
animal models is dual-energy x-ray absorptiometry (DXA), which measures whole body, 
or regional measures of lean and fat mass, as well as bone mineral content. Studies using 
male and female rodent models have demonstrated that a high fat diet (39% - 59% kcal 
from fat) can lead to a higher fat mass [49, 50] , and lower lean mass [44]. These studies 
fed diets that were either high in saturated fat [44, 50], or high in monounsaturated fatty 
acids and/or polyunsaturated fatty acids [49, 51], each of which elicited changes in body 
composition (higher fat mass [49, 50] or lower lean mass [44]). Whole body bone mineral 
content is also impacted by the consumption of a high fat diet. A study in growing male 
rats has shown that bone mineral content is lowered after 10 weeks of high fat feeding 
(38.5% kcal from fat – vegetable oil) in the absence of obesity [51]. Investigators of this 
study speculate that increases in fat mass, particularly visceral fat mass, negatively 
impacts bone accretion, which may interfere with calcium deposition during bone 
modeling [51]. Lower whole body bone mineral content or bone mass may lead to 
weaker bones that are more prone to fracture. From the evidence provided, it is clear that 
a high fat diet can change body composition, which is of particular concern given the 
typical Canadian diet is higher in fat intake, and the steady rise in obesity and associated 
chronic diseases such as cardiovascular disease and type II diabetes [34].  
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2.2. Effect of high fat diet consumption on rodent bone health 
  Bone strength, characterized by two important components - bone quantity and 
bone quality - is the hallmark for determining overall bone health status in animal 
models. Bone quantity is the amount of bone mineralized, which is described as bone 
mineral content (BMC) and bone mineral density (BMD). Bone mineral density is 
determined by calculating the amount of bone deposited (BMC) in a specific area, which 
is measured using DXA. Bone quality is characterized by the structure of cortical and 
trabecular bone. Bone quality is often examined using specialized imaging equipment 
such as computed tomography (CT) which can provide details of cortical and trabecular 
bone structure. The specific components of bone microarchitecture that provide 
information on overall bone quality in animal models are discussed further in section 
2.2.1. 
  Although bone strength is the hallmark of determining overall bone health and 
relative fracture risk, it is difficult to directly measure in humans. DXA is unable to 
measure bone strength, however it provides information on overall bone mass, more 
specifically BMD. The use of BMD as a surrogate measure of determining the risk of 
developing a fragility fracture has been validated, and is used by health care professionals 
to determine an individual’s risk of developing osteoporosis [52]. It is most clinically 
relevant to measure BMD with DXA at the femoral neck (hip fracture) and spine 
(vertebral compression), as these are common sites of fractures [53] associated with 
marked morbidity and premature death [54]. Current research has demonstrated that the 
gold standard for determining bone strength, and subsequently fracture risk, is through 
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the combination of BMC and BMD by DXA, as well as microstructural properties from 
CT, in excised femurs from human cadavers [55]. However, DXA is still primarily used 
in clinical settings, as it is cost-effective with minimal exposure to radiation [56]. 
  Considering that nutrition can modulate bone health, it may be important to 
establish links between a high fat diet and overall bone health. Studies examining the 
impact of a high fat diet on bone health often use animal models, more specifically 
rodents, as it is difficult to measure the true properties of bone (i.e. bone strength) in 
humans. Bone strength in rodents is determined by fracturing the excised bone, and 
obtaining its ‘peak load’, which is the maximum force a bone can withstand before 
fracturing. Peak load is a surrogate measure of bone strength, a reason why rodent models 
are often used in intervention studies. It has been shown that a high fat diet may impact 
trabecular bone more than cortical bone [43, 57, 58], which will be discussed further in 
subsequent sections. This may be due to the high metabolic activity in trabecular bone 
[59], with greater nutrient delivery, compared to cortical bone. Furthermore, weight-
bearing bones may respond to a high fat diet to an even greater extent compared to non-
weight-bearing bones, due to a higher rate of bone turnover [60, 61]. Therefore in rodent 
models, it is particularly important to examine the impact of hindlimb bones such as the 
femur and tibia, as these are considered weight-bearing [62]. It is also important to 
investigate whether diet can modulate bone at different skeletal sites, particularly the 
spine, which is known to be rich in trabecular bone. The effect of a high fat diet on rodent 
bone health is further discussed in section 2.2.1. 
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2.2.1. Effect of high fat diet consumption on bone quantity, quality, strength, and fatty 
acid composition in rodents 
As previously described, bone health is a measure of bone strength, which is often 
determined by bone quantity (mineral content) and quality (structure). It is the 
investigation of these three components that will provide the greatest understanding of 
overall bone health. However, when determining the impact of a high fat diet on rodent 
bone health, there are only a handful of studies in the literature, and only one has 
investigated all three of these important outcomes.  
A study by Lanham et al. investigated the impact of a high fat diet (22% fat by 
weight – 18% lard, 4% soya oil) on femoral density, structure and strength of growing 
C57BL/6 mice [58]. A strength of this particular study was that the levels of protein, 
vitamins, and minerals were increased on an energy basis to account for the elevated 
levels of fat in the high fat diet [58]. It is important to consider that the higher fat content 
in a high fat diet subsequently increases overall energy provided, as it will change the 
relative energy contribution of other nutrients that are important for bone health (i.e. 
calcium, vitamin D, protein). When energy content of a diet is higher per kg of diet, it is 
important to proportionately adjust for micronutrients, as well as protein content, to 
account for the higher amount of energy provided per kg of diet. This is to ensure that 
the proportion of vitamins and minerals, as well as protein, is similar to that of the 
control diet and thereby enables investigators to directly evaluate the effects of the fat in 
the diet on overall bone health.   
Mice were fed the high fat or control (5% corn oil by weight) diet from weaning 
to 7.5 months of age, at which point femoral density and structure were determined 
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using micro-computed tomography (µCT), and strength using a materials testing system. 
Femur density was greater in both males and females fed the high fat diet compared to 
mice fed the control diet [58], which may have been a result of excess nutrient 
consumption. Lanham et al. also found differences in trabecular, but not cortical 
structure in femurs of mice fed the high fat diet [58]. Bone volume and trabecular 
spacing were greater in females fed the high fat diet, but not males, when compared to 
mice on a control diet. However, despite these changes in femoral density and trabecular 
structure, there were no differences in peak load (the maximum load a bone can 
withstand before fracture – measure of bone strength) at the femur midpoint [58]. 
Considering the dietary adjustment of nutrients (protein, vitamins, minerals) in the high 
fat diet, it is possible to conclude that a high fat diet containing 22% fat by weight may 
not be detrimental to overall bone health. However, this study only examined the impact 
of a high fat diet on one skeletal area. It may be important to continue investigations in 
other skeletal sites, such as vertebrae (rich in trabecular bone), to determine whether 
effects are site-specific. Moreover, bone strength was only measured at the femur 
midpoint, which is a site that is rich in cortical bone. Considering that cortical bone 
structure did not change, but trabecular bone did by greater trabecular spacing, it may be 
important to determine bone strength at sites rich in trabecular bone (e.g. femur neck, 
vertebrae).  
Another study investigated whether the quality of dietary fat had differing effects 
on bone quantity and strength. Lau et al. fed 1.5 month old male Sprague Dawley rats 
standard chow, or one of three different high fat diets containing different types of fat as 
the fat source. Each of the high fat diets contained 20% total fat by weight, and were 
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enriched in either: saturated fat (18% coconut oil, 2% soybean oil by weight); n3 
polyunsaturated fat (20% flaxseed oil by weight); or n6 polyunsaturated fat (20% 
safflower oil by weight) [63]. After approximately 2 months of feeding, BMC and BMD 
of excised femurs were determined using DXA, and peak load at the femur midpoint 
was measured with a materials testing system. There were no differences in femoral 
BMC or BMD between groups [63]. Furthermore, rats fed the diets high in n3 and n6 
polyunsaturated fats had greater peak load at the femur midpoint when compared to 
chow-fed rats, even when adjusted for body weight. However, there were no differences 
in femur midpoint peak load in rats fed the high saturated fat diet [63], which is 
consistent with findings from the study by Lanham et al. [58]. Therefore, this study by 
Lau et al. demonstrates that a diet high in saturated fat does not alter BMC, BMD, or 
femur strength after 2 months of feeding [63]. The findings that a high saturated fat diet 
did not contribute to differences in BMC and BMD in this study [63] are inconsistent 
with those from the study by Lanham et al. [58], which showed increased femoral 
density [58]. Differences in study findings may be due to the duration of dietary 
intervention, as mice in the study by Lanham et al. [58] were fed the high fat diet for a 
longer period of time compared to the duration of feeding in the study by Lau et al. [63], 
where those mice may have adapted to excess nutrient consumption with greater bone 
accretion. The quality of saturated fat may have played a role in differences in study 
findings, where the study by Lau et al. [63] used coconut oil (mainly medium-chain fatty 
acids), whereas the dietary intervention in the study by Lanham et al. [58] incorporated 
lard (mainly long-chain fatty acids). Medium-chain fatty acids are readily absorbed in 
the stomach, entering the portal system, and are preferentially oxidized compared to 
 
 
17 
 
long-chain fatty acids [64]. In rodents, there are fewer medium-chain fatty acids 
compared to long-chains found in triglycerides [65]. The preferential oxidation of 
medium-chain fatty acids, as provided in the dietary intervention through coconut oil, 
may have contributed to the lack of increased bone mineral content in the study by Lau 
et al. [63]. Elevated bone mineral density as an effect of consumption of a high saturated 
fat rich in long-chain fatty acids (provided by lard) in the study by Lanham et al. [58], 
may have been a result of increased storage of these fatty acids in bone, potentially 
promoting bone modelling. Nonetheless, differences in study findings may have been 
mediated by the quality of dietary fat, rather than the quantity. Furthermore, as 
previously discussed, it may be important to determine whether effects are consistent 
amongst each bone type, especially considering the high metabolic activity of trabecular 
bone [59], which may render it more sensitive to changes in diet compared to cortical 
bone. 
A study by Ward et al. investigated the impact of a Western-style diet on bone 
quantity and strength in femurs of Fischer 344 rats [66]. The Western-style diet designed 
in this study was high in fat (20% corn oil by weight) and sucrose, with low levels of 
calcium, vitamin D, folic acid, and fibre. Rats, approximately 2 months of age, were fed 
the Western-style diet or control diet for approximately 4 months. Bone mineral content 
(BMC) was measured using the ash technique [66], where femurs were dried and ashed 
in a furnace before mineral content was calculated ([dry mass – ash mass] x 100/ dry 
mass) [67]. Femur midpoint peak load determined with a materials testing system [66]. 
BMC was significantly lower after approximately 4 months of feeding, as was femur 
midpoint peak load. It is difficult to truly attribute these detrimental effects on bone to 
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the level of fat in the diet. Femurs may be weaker due to the lack of sufficient levels of 
calcium and vitamin D, which are known to be important for bone health [68, 69]. 
Parhami et al. demonstrated that lifelong consumption of a high saturated fat diet 
can negatively impact the quantity of bone [70]. In this study, 1 month old male 
C57BL/6 mice were provided a high saturated fat diet (16% total fat by weight; 
approximately half from cocoa butter) for 4 and 7 months. The diet was intended to 
induce atherosclerosis, with additional cholesterol (1% by weight), which was mixed 
with standard mouse chow (75% chow by weight). Both BMC and BMD of femurs and 
fourth lumbar vertebra (LV4) were measured using quantitative CT at 4 and 7 months of 
age [70]. At 4 months of age, femoral BMD in 3 of 8 scanned regions was lower due to 
high fat feeding. Later in adulthood at 7 months of age, femoral BMD was lower in 6 of 
8 sites, with lower BMC in the femur and LV4 of high fat fed rats [70]. This study is the 
only one to demonstrate that a diet high in saturated fat can lead to lower bone mineral. 
This is interesting as the level of fat used in the study by Parhami et al. [70] was lower 
than that implemented in those previously described ([58, 63, 66]). Furthermore, despite 
using the same experimental model (C57BL/6) and studying mice at a similar age (7 and 
7.5 months old) as the study by Lanham et al. [58], the lowering of BMC and BMD in 
the study by Parhami et al. [70] are conflicting as Lanham et al. found an overall 
increase in femoral density [58]. It is difficult to directly compare and contrast these 
findings as the instruments used to determine bone quantity were not the same 
(quantitative CT versus µCT), and will produce different measurements due to the 
nature of the machine. It is clear that future research is needed in this area considering 
the discrepancies in study findings. 
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Two studies by Cao et al. examined the effects of a high fat diet in a growing 
model, using 1.5 month old male C57BL/6 mice [43, 57]. Mice were fed a high 
saturated fat diet (23.6% total fat by weight – 20.7% lard, 2.9% soybean oil) for 3.5 
months, and cortical and trabecular structure of tibias and femurs were determined using 
µCT [43, 57]. Though no differences were examined in cortical bone, mice fed the high 
fat diet had increased trabecular separation and lower trabecular number, despite being 
obese [43, 57]. These results indicate the tibias and femurs from high fat fed mice were 
more porous compared to animals fed a control diet, creating a weaker structure, which 
can contribute to a greater risk of fracture. Furthermore, these studies [43, 57] provide 
evidence that increased loading due to higher body weights such as in obesity may not 
necessarily be protective of overall bone health. These findings are in accordance with 
those from Lanham et al., which demonstrated that femoral trabecular structure, but not 
cortical structure, was impacted due to consumption of a high fat diet [58]. It may be 
that trabecular bone is more sensitive to dietary interventions, considering it is more 
metabolically active. However, it is not known whether these alterations in trabecular 
structure translate to changes in bone strength in skeletal sites rich in trabecular bone, 
such as the femur neck and vertebrae. Further investigation is required in this area, as 
trabecular structure is a predictor of fracture risk in osteoporosis [71, 72].  
The studies discussed above demonstrate that high fat diet consumption can alter 
bone mineral [70], structure [43, 57] and strength [66] in rodents, which may ultimately 
alter the risk of fracture. Whether this is due to direct effects of fatty acids present in 
bone or due to a secondary mechanism is not known. It is well established that dietary 
fat intake has the ability to alter the fatty acid composition of cortical bone. In general, 
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the composition of fatty acids in the dietary fat consumed reflects the fatty acid 
composition of cortical bone, as determined by animal models [63, 73, 74]. Most studies 
that have investigated the impact of a high fat diet on fatty acid composition in bone 
have focused on diets high in n3 and n6 polyunsaturates (PUFAs) [74, 75]. However, the 
effect of a high saturated fat diet on bone fatty acid composition is not well studied. 
Whether elevations saturated fatty acids in cortical bone results in functional changes 
(i.e. reduced bone strength) remains to be established. This is an important area of 
discovery considering the typical Canadian diet, and  supporting evidence from animal 
models that a diet high in saturated fat can lead to lower bone quantity [63, 66, 70] and 
altered structure [43, 58].  
It is evident that a high fat diet can modulate bone health; however there are 
discrepancies in study findings that make it difficult to make comparisons. Although 
most studies measure bone mineral, the instruments amongst studies have all varied. 
Consistency in methods and instruments used amongst studies may facilitate 
comparisons. Furthermore, studies that have investigated the impact of high fat diet 
consumption on bone structure have shown that trabecular bone is preferentially altered, 
with no changes in cortical bone [43, 57]. However, whether trabecular bone is altered at 
various skeletal sites remains to be determined. In addition, the current studies have only 
measured bone strength at sites rich in cortical bone. Considering any structural 
alterations (i.e. increased trabecular spacing [58]) due to high fat diet consumption 
appear to be restricted to trabecular bone, bone strength should be measured at 
trabecular-rich sites (e.g. femur neck, vertebrae). Only one study by Lanham et al. [58]  
has appropriately adjusted for the level of protein, vitamins, and minerals in the high fat 
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diet. Further investigation in this area should adjust for the level of these important 
nutrients to appropriately attribute any observed effect in bone, to the level of fat in the 
diet, and not inadequate intake of these nutrients. Further research in the area of bone 
fatty acid composition and its impact on bone strength is needed. This would provide a 
greater understanding of the functional importance of changes in bone fatty acid 
composition. Lastly, no study to date has investigated bone quantity, quality, strength, 
and fatty acid composition in one study. This would provide a more comprehensive 
understanding of overall bone health. 
 
2.3. Impact of high fat diet consumption on plasma hormones 
As discussed in section 2.1, consumption of a high fat diet in rodents is known to 
increase overall adiposity [49, 50], which is associated with increased levels of 
circulating pro-inflammatory cytokines [76] released from adipocytes. A high fat diet 
may lead to an increase in visceral adipose tissue, whose release of pro-inflammatory 
cytokines can lead to the development of morbidities such as non-alcoholic fatty liver 
disease. Liver disease is manifested by increased delivery of pro-inflammatory cytokines 
and fatty acids, as visceral adipose tissue drains directly into the portal system. In 
addition, the presence of certain pro-inflammatory cytokines can also impact bone health. 
More specifically in high levels, these cytokines are known to increase bone resorption 
[77] and inhibit bone formation [78]. Pro-inflammatory cytokines, chemokine attractants, 
and associated hormones will be discussed in terms of their relation to high fat feeding 
and increased fat mass, as well as bone health, in sections 2.3.1 – 2.3.6.  
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2.3.1. Leptin 
 Leptin is an adipokine released by white adipose tissue [79] that exerts its effects 
on body composition and bone mass. Circulating leptin is positively correlated with fat 
mass [80], is an appetite suppressor, and known regulator of body weight [81]. It is well 
established that a high fat diet leading to obesity causes drastically increased circulating 
levels of leptin [80]. Greater energy intake from consumption of a high fat diet may lead 
to increased fat storage, thereby elevating leptin concentrations above normal circulating 
levels. Knowing that leptin is an appetite suppressor, it is clear the leptin functioning is 
impaired in obesity. High circulating levels of leptin without normal leptin functioning is 
known as leptin resistance [82]. Leptin resistance occurs when there is a lack of a 
response (i.e. suppressed appetite) after provision of endogenous and /or exogenous 
leptin [83]. The concept of leptin resistance has been greatly debated amongst 
investigators and the mechanisms to which this may occur are not clearly defined. Some 
believe leptin resistance occurs as a result of signalling or transport defects. More 
specifically, alterations in signalling through leptin receptor b (LRb) in the arcuate 
nucleus [84], impaired transport from plasma across the blood-brain barrier to reach a LR 
[85], or promotion of processes that inhibit LRb signalling (e.g. inflammation) [86]. 
Current research in the area is testing the conditions in which these hypotheses are more 
likely to occur. 
There is controversy at present in regards to the literature on the effects of leptin 
on bone. Studies are reporting that leptin has either antiosteogenic or osteogenic effects 
on bone, which has been studied extensively in in vitro and in vivo models, as well as 
clinical trials. The antiosteogenic impact of leptin is thought to act through the central 
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relay of leptin, specifically indirectly by binding to the LR on the hypothalamus. This 
stimulates the release of norepinephrine, which binds to the β-adrenergic receptor on the 
osteoblast, inhibiting osteoblastic function in mice [87]. This antiosteogenic effect was 
first discovered in mice with leptin (ob/ob) or leptin-receptor (db/db) deficiencies, which 
have characteristic high bone mass phenotypes with the inhibitory effects of leptin 
diminished [78]. Furthermore, central regulation of leptin was proven to be 
antiosteogenic as leptin infusion (intracerebreventricular – stimulates central relay of 
leptin) in ob/ob mice for 28 days lowered bone mass, as discovered by histology of 
vertebrae [78].  
The osteogenic impact of leptin occurs outside of the central relay, where 
circulating leptin can exert its effects directly on bone. In contrast to the antiosteogenic 
effects of leptin when centrally regulated, peripheral leptin is thought to have potential 
anabolic effects on bone, specifically through upregulation of bone formation. One study 
that provided exogenous leptin to ob/ob rodents discovered that leptin increased bone 
mass following administration [88]. This evidence suggests that leptin secreted from 
adipose tissue can modulate bone formation. Furthermore, greater fat mass attributed to a 
high fat diet, producing even greater levels of leptin may have a more potent anabolic 
effect on bone.  
It is known that obese individuals have high BMD compared to individuals of 
healthy weight [89], due to increased mechanical loading from excess body weight. 
Leptin resistance may also contribute to this increase in BMD in obesity. With high 
circulating levels of leptin, there is a greater chance for leptin to bind to its receptor on 
bone, which consequently has osteogenic effects. Furthermore, the mechanisms in which 
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leptin resistance occur, stem from the brain where the central relay of leptin. As 
previously mentioned, the effects of leptin from the central relay seem to have 
antiosteogenic effects. Therefore, it may be that leptin resistance occurs in the brain, 
preventing the central relay of leptin and its antiosteogenic effects. However, this 
relationship is a speculation and remains to be determined. Despite discrepancies in the 
literature, it is evident that leptin has potent effects on bone. Any changes to circulating 
levels of leptin due to diet, increases in fat mass, or disruptions in central regulation of 
leptin, will subsequently impact bone homeostasis.  
 
2.3.2. Tumour Necrosis Factor-Alpha (TNF-α) 
 TNF-α is a pro-inflammatory cytokine released by a number of different cells, 
including macrophages, lymphocytes, and adipose tissue [90]. High circulating levels of 
TNF-α is an indicator of low-grade inflammation, commonly found in obesity [91]. TNF-
α has been shown to be secreted progressively more by adipose tissue as fat mass 
increases [92]. Therefore, high fat diet-induced increases in fat mass will also contribute 
to higher levels of TNF-α. At the tissue level, higher circulating levels of TNF-α may 
contribute to dysfunction of the tissues affected. For example, TNF-α is known to reduce 
insulin sensitivity in adipose tissue when found in high amounts, which can lead to 
insulin resistance [93]. TNF-α responds in accordance to changes in body composition 
and fat distribution, and is a potent contributor to the development of other health 
complications especially in situations of chronic inflammation [93].  
 TNF-α not only contributes to chronic inflammation, but has detrimental effects 
on bone health as well. TNF-α down-regulates production of osteoblasts and promotes 
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production of osteoclasts, favouring bone resorption [94]. There are multiple ways in 
which TNF-α inhibits bone formation, which will be discussed in brief. TNF-α inhibits 
type I collagen production [95], lowers levels of osteocalcin and decreases sensitivity to 
vitamin D, and inhibits normal function of alkaline phosphatase (required for bone 
mineralization). In addition, TNF-α can prevent osteoblast differentiation [95], which 
would also contribute to slower bone formation and promoting greater bone resorption. 
TNF-α also acts in a number of ways to promote bone resorption. TNF-α increases 
osteoclastogenesis, mediated by NF-κB, by upregulation of RANK expression [94]. 
 From the review of the literature, it is clear that TNF-α is a contributor of low-
grade chronic inflammation as seen in individuals with elevated fat mass (e.g. obesity). 
Additionally, its effects can be deleterious at the tissue level, particularly in bones by 
promoting bone resorption. This may eventually contribute to weaker bones as with 
greater rates of bone resorption. A high fat diet per se, does not directly promote TNF-α 
production, however when paired with a sedentary lifestyle, greater fat mass can 
accumulate. This may contribute to a higher circulating level and increased expression of 
this pro-inflammatory cytokine, which can ultimately lead to greater health problems if 
not dealt with.  
 
2.3.3. Interleukin-6 (IL-6) 
 IL-6 is a pro-inflammatory cytokine with multiple functions, and like TNF-α is 
secreted by a number of different cells, including adipocytes. Levels of IL-6 are 
correlated with overall fat mass [96], which is secreted in highest amounts by visceral fat 
(compared to subcutaneous fat) [97, 98]. It has also been established that IL-6 secreted by 
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visceral adipose tissue is released into the portal vein and can contribute to systemic 
inflammation in obese women [99]. A high fat diet may contribute to accumulation of fat 
mass (especially visceral), leading to high circulating levels of IL-6 and subsequently 
lead to systemic inflammation.  
 IL-6 is also secreted within bone, particularly by osteoblasts [77, 100], however 
its role does not favour bone formation. Bone resorption appears to be indirectly 
mediated by IL-6 through its receptor, IL-6R, as increasing osteoclast production has 
been observed in vitro [101, 102]. IL-6 also stimulates and enhances the effects of other 
inflammatory cytokines, such as TNF-α when present, which further contributes to 
increased osteoclastogenesis [103] and bone resorption. Therefore in the presence of a 
high fat diet, greater fat mass accumulation and subsequent increases in circulating levels 
of IL-6 may also have detrimental effects on bone remodelling, in the favour of bone 
resorption.  
 
2.3.4. Monocyte chemoattractant protein-1 (MCP-1) 
MCP-1 is a chemokine responsible for the translocation of monocytes during 
inflammation [104]. The effects of MCP-1 with increased adiposity, as can be induced 
with a high fat diet, can promote chronic low-grade inflammation often observed in 
obesity [105]. Low-grade inflammation is thought to be, in part attributed to increased 
macrophage infiltration of adipose tissue, mediated by MCP-1 [105]. It is recognized that 
levels of MCP-1 in plasma and adipose tissue are associated with the level of adiposity, 
and are secreted in greater amounts by visceral adipose tissue compared to subcutaneous 
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[42]. Low-grade inflammation can not only contribute to insulin resistance and 
atherosclerosis, but can also negatively impact bone health.  
MCP-1 is not always found in healthy bone, but is preferentially expressed in 
conditions of inflammation [106, 107] for recruitment of monocytes. Studies using a cell 
culture model of human osteoblasts have demonstrated that osteoblasts secrete MCP-1in 
presence of a pro-inflammatory cytokine, IL-1 [108]. Additionally, it has also been 
shown that MCP-1 is present during bone remodelling, as discovered in mice following 
tooth eruption (where bone formation and resorption occur simultaneously) [104]. Bone 
remodelling has also been shown to be induced by MCP-1, through osteoclast and 
precursor monocyte recruitment to the site of remodelling in cell culture. Parathyroid 
hormone (PTH) stimulates the release of MCP-1 by osteoblasts, which ultimately exert 
effects on osteoclast function, and can also upregulate osteoclastogenesis. In situations 
where PTH is transiently elevated in cell culture, MCP-1 can help exert anabolic effects, 
as bone formation would still exceed bone resorption. However, when PTH levels are 
elevated for extended periods of time, MCP-1 can have catabolic effects on bone, 
favouring resorption over formation [109]. Therefore, continuous stimulation and 
secretion of MCP-1 has the potential to tilt bone remodelling in favour of resorption, 
which can be detrimental to overall bone health if sustained over time.  
 
2.3.5. 17β-Estradiol 
 Estradiol is a form of estrogen secreted by the ovaries and is a major regulator of 
both body composition and bone mass [110, 111]. During menopause and subsequently 
after, women experience changes in body composition, particularly increases in fat mass 
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[110]. Moreover, post-menopausal women accumulate more fat mass subcutaneously and 
viscerally, which is accompanied by lower rates of fat oxidation [112, 113]. Though total 
fat mass is known to increase, there is also a marked increase in abdominal adiposity 
[112, 113]. Furthermore, post-menopausal women who receive hormone replacement 
therapy (HRT) have reduced fat mass accumulation compared to women who do not 
receive HRT [114]. Ovariectomized rats (estrogen deficient), have characteristic 
increases in visceral adiposity that can be diminished with administration of estradiol 
[110]. The effects of estradiol on body composition and fat mass distribution are not only 
true for women, but are also evident in men (and rodents) with aromatase deficiency. 
Aromatase deficiency prevents the production of estrogen in men and knockout animal 
models, leading to a stereotypic phenotype of increased adiposity compared to normal 
men [115, 116]. Therefore, it is evident that normal circulating levels of estrogen are 
important for maintaining lipid homeostasis and distribution of fat, which can be easily 
disrupted when levels become too low [112]. 
 Estradiol and other estrogens have powerful effects on bone remodelling, with 
receptors located on both osteoblasts and osteoclasts [117]. Estradiol acts mainly through 
estrogen receptor α (ERα) on osteoblasts and osteoclasts [118], each receptor with a 
separate function. ERα located on osteoblast precursors promote formation of cortical 
bone, while ERα located on osteoclasts promote trabecular bone formation [117, 119]. 
Estradiol has anabolic effects on bone by promoting osteoclast apoptosis, and decreasing 
osteoclastogenesis for overall decreased resorption. Not only is resorption decreased, 
bone formation rate is further improved [111].  
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 It is clear that normal circulating levels of estradiol is imperative for promoting 
healthy fat distribution, and maintenance of bone health. In situations where levels of 
estradiol deviate from normal ranges, such as in menopause, subsequent changes in fat 
mass distribution and bone health occur as a result. Given the increased consumption of a 
Western diet containing high levels of saturated fat, it is important to understand the 
impact of fat on estradiol concentrations and its impact on body composition and bone 
health. 
 
2.3.6. Progesterone 
 Progesterone is another female sex hormone known to exert its effects on a 
number of tissues and organs, including the uterus, adipose, and bones. The effects of 
progesterone on body composition and fat mass distribution are not as well defined as 
estrogen, however some studies have determined that progesterone may be involved in 
lipid synthesis. Female rats given progesterone gained more weight than rats not exposed 
to progesterone [120], which translated into greater total body fat [121]. Additionally, 
women who used a contraceptive made of progesterone also had experienced weight gain 
and increases in the level of whole body fat mass [122]. Administration of progesterone 
to 3T3-L1 preadipocytes led to differentiation to adipocytes [123]. Other studies in vitro 
found that progesterone stimulates the activity and increases gene expression of fatty acid 
synthase, an enzyme responsible for long-chain fatty acid synthesis [124]. There is some 
evidence that progesterone leads to the characteristic gynoid (lower body) distribution of 
adipose tissue in women. Administration of progesterone in female rats also increased 
gene expression of lipogenic enzymes within inguinal adipose tissue [125], which may in 
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part contribute to lower body adipose storage and distribution. Similar to estrogen, 
absence of progesterone such as during menopause, can lead to visceral fat storage [113], 
which has multiple metabolic consequences.  
 As previously mentioned, progesterone has anabolic effects on bone which 
become diminished during menopause. Though it does not have a particularly potent 
effect on bone like estradiol, progesterone has an important function in regulating bone 
formation [126]. Progesterone receptors are evident in human osteoblast-like cells [127], 
and when supplemented in primary culture of osteoblasts, progesterone increases 
proliferation in human and rat cells [128, 129]. The effects of progesterone on reversal 
and prevention of bone loss has been studied extensively in medications combined with 
estrogen. Although not commonly used as a medication to treat rapid bone loss, some 
studies have reported that progesterone alone is effective in slowing the rate of bone loss 
in post-menopausal women [130, 131].  
 Progesterone, in normal physiological levels, is an important mediator of non-
threatening fat storage (gynoid) and bone formation. When levels are low, its role in 
regulating these important functions in adipose tissue and bone become disrupted as 
described above. It is unclear whether a high fat diet has the potential to alter levels of 
progesterone in women, which may be fundamentally important to determine considering 
the typical Canadian diet. 
 
Chapter 3.0: Nutritional Programming 
While lifestyle factors such as diet and physical activity are known to modulate 
risk of chronic disease development [132-135], less understood is the role of maternal 
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diet in chronic disease development among offspring. However, the intrauterine 
environment is a critical determinant of childhood and subsequent adult health as 
metabolic perturbations in utero largely impact body weight regulation and fetal skeletal 
development [136]. Therefore, an overall unhealthy or nutritionally unbalanced maternal 
diet during pregnancy can alter offspring nutrient availability that can ultimately impact 
offspring growth and development. More specifically, it has been discovered that long 
lasting changes in offspring phenotype may occur as a result of a poor maternal diet that 
may contribute to increased risk of disease in adulthood. These long lasting changes in 
offspring phenotype are a result of ‘nutritional programming’- which is the effect of a 
food or a food component exerted on offspring when exposure occurs in early life. 
One particular event brought about further investigation of nutritional 
programming, which was the Dutch winter famine (November 1944 – April 1945) 
occurring in the last winter of World War II [137]. The birth cohort derived from the 
Dutch winter famine – that resulted from a harsh winter limiting agricultural production 
as well as the Germans limiting food supply to regions of Holland - has provided a 
unique opportunity to investigate the true effects of maternal diet on offspring health and 
development, being a true ‘natural experiment’ [137]. The birth cohort was derived from 
mothers deprived of food before, during, and prior to pregnancy during the Dutch winter 
famine. Studies over the past two decades have found associations between poor adult 
health, such as the increased risk of developing chronic diseases, in offspring whose 
mothers were exposed to the Dutch winter famine [138, 139]. This has provided 
framework for current investigations in the topic of nutritional programming due to 
maternal under-nutrition, which is being extensively studied in animal models.  
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Though it is imperative that maternal under-nutrition be investigated, especially 
considering the numerous countries in poverty, it is also of particular importance to 
investigate the impact of maternal over-nutrition on offspring health. This is important 
given the rise in obesity worldwide and greater food accessibility. There is evidence in 
animal models to support that offspring from mothers fed vitamins or multivitamins had 
long-lasting changes in overall health [140, 141]. More specifically, mothers exposed to 
the multivitamin had male offspring that were obese and hyperphagic, with glucose 
intolerance [140, 141]. Given this hypothesis of the long-term consequences on offspring 
health due to maternal over-nutrition, it is thought that obesity is also programmed in 
utero due to maternal diet. Recent evidence has discovered genomic alterations through 
DNA methylation and changes in chromatin structure through histone modification in 
offspring due to suboptimal maternal diet [58]. This creates changes in DNA expression, 
which is one of the proposed reasons for alterations in offspring phenotype. A particular 
example of DNA methylation is shown in a study by Chen et al., which examined the 
effects of maternal high fat diet consumption on fetal bone development [142]. Fetal mice 
from mothers fed a high fat diet during pregnancy had delayed bone development at 
embryonic day 18.5, despite typical intramembranous ossification occurring at embryonic 
day 15 in mice [142]. This effect may be facilitated by methylation of HoxA10, an 
important modulator of PPARγ (transcription factor for adipogenesis) and Runx2 
expression [142].   
It is also important to understand whether there are particular periods in which 
offspring are most vulnerable to an unhealthy maternal diet. Evidence from the Dutch 
winter famine describes that exposure of famine in early gestation was associated with 
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the development of a greater number of chronic diseases (e.g. 5 diseases – breast cancer, 
obesity, coronary heart disease, glucose intolerance, atherogenic lipid profile) compared 
to individuals exposed to the famine in late gestation (e.g. 1 associated disease – glucose 
intolerance) [143]. Therefore, although any nutritional insult during pregnancy can have 
long-lasting impacts, it may be that early gestation is the critical period in which 
offspring are most vulnerable to maternal diet. This is because early gestation, or the first 
trimester, is the time in which the fetus is rapidly growing, and organs are developing 
[144]. 
It is essential to explore the effects of nutritional programming in both male and 
female offspring, however it may be of particular interest to look closely at the effects in 
female offspring as existing literature already identifies maternal health as a predictor of 
infant health [139, 145-147]. Permanent changes in female offspring genotype may also 
have the ability to be passed to subsequent generations during future pregnancy. 
Therefore, it is important to study female offspring to understand the consequences of 
poor maternal health and nutrition to protect the health of future offspring. Current 
knowledge regarding the role of maternal nutrition prior to, and during pregnancy and 
lactation on offspring body composition, bone development, and circulating hormones 
will be discussed in sections 3.1-3.3.  
 
3.1. Effect of maternal high fat diet consumption on body composition in female 
rodent offspring 
It is well established that elevated fat mass, especially visceral fat, is a risk factor 
for the development of chronic diseases such as cardiovascular disease [46] and insulin 
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resistance [45, 148]. With the evidence that maternal diet programs offspring health [140, 
141], it is important to determine whether offspring body composition is altered as a 
result of a maternal high fat diet. A number of studies have investigated the effects of 
maternal diet on offspring body composition in various conditions [17, 44, 149, 150]. 
Some studies have only focused on the impact of maternal diet, exposure of maternal diet 
occurring solely in utero [17, 150], while others have investigated whether exposure to 
maternal diet postnatally (lactation and/or post-weaning) has greater effects on offspring 
health [44, 149, 151]. Furthermore, the age or time of exposure of maternal diet, as well 
as the age at which offspring were studied, have also differed amongst studies. These 
individual aspects regarding the impact of a maternal high fat diet on female offspring 
body composition are highlighted in Table 1, and will be explored in detail below. 
Adverse effects of maternal high fat feeding are evident in female offspring in 
early life. However only two studies to date have investigated the impact of maternal 
high fat feeding on offspring body composition in early life. Krasnow et al. investigated 
whether various durations of maternal exposure to a high fat diet (35% fat by weight - 
32% lard, 3% soybean oil) had different impacts on body composition in newborn 
C57BL/6 female offspring mice [150]. The second study was by Sun et al., which 
investigated the impact of feeding Sprague Dawley rats the same high fat diet used in the 
study by Krasnow et al. (35% fat by weight - 32% lard, 3% soybean oil) throughout 
pregnancy and lactation on female offspring body composition at weaning. Offspring 
were cross-fostered at birth (i.e. females from dams fed high fat diet were fed by dams 
fed control diet during lactation) [17], so that the impact of high fat diet exposure in utero 
could be studied separately from the diet consumed while suckling. This was done to 
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decipher whether differences detected at weaning were due to prenatal or postnatal diet.  
[17].  
Regardless of the length of exposure of mothers to the high fat diet, all offspring 
from these mothers had overall lower whole body lean mass [17] and greater fat mass 
compared to offspring from mothers fed a control diet [150]. However in the study by 
Sun et al., offspring from mothers fed a high fat diet, cross-fostered to mothers fed chow 
diet did not have differences in body composition [17]. Rather, a postnatal high fat diet 
caused greater overall subcutaneous and visceral fat (as % of total fat), with lower lean 
mass, in female Sprague Dawley rat offspring at postnatal day (PND)10 and PND21 
compared to females fed chow postnatally [17]. Therefore, there is evidence that a 
maternal high fat diet can alter female offspring body composition at birth, by increasing 
fat mass and fat:lean mass ratio [150]. However, once females are exposed to a healthier 
diet during suckling, the maternal high fat diet does not seem to have an impact on 
offspring body composition [17]. Despite this evidence, further research in the area 
should be investigated to develop definitive answers on the impact of a maternal high fat 
diet on female offspring body composition in early stages of life. 
The influence of a maternal high fat diet on female offspring body composition at 
adulthood has also been investigated. Overall, 3 of the 4 studies that examined this in 
female offspring at adulthood (4,5 and 9 months of age) found that fat mass and fat:lean 
mass ratio were increased as a result of a maternal high fat diet [44, 149, 151]. These 
studies used similar maternal high fat diets, which contained either 24% total fat by 
weight (21% lard, 3% soybean oil [44, 151]) or 22% total fat by weight (18% lard, 4% 
soya oil [149]). In the study by Howie et al., females Wistar rats from mothers fed a high 
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fat diet (24% total fat by weight - 21% lard, 3% soybean oil) throughout life, plus during 
pregnancy and lactation, had similar increases in fat:lean mass ratio than females from 
mothers fed the high fat diet solely during pregnancy and lactation [44].  The findings 
from this study confirm that maternal consumption of a high fat diet can impact female 
offspring body composition in adulthood. Furthermore, this study provides evidence that 
timing of the maternal high fat diet rather than duration, is a more potent modulator of 
female offspring body composition in adulthood (~5 months of age) [44]. However, the 
study by Connor et al. contradicts this conclusion that timing of maternal high fat feeding 
dictates changes in female offspring body composition in adulthood [151]. Connor et al. 
also found that female Wistar rat offspring from mothers fed a high fat diet throughout 
pregnancy and lactation had higher fat:lean mass ratio, but only in females fed a post-
weaning high fat diet [151]. In the study by Howie et al., this finding occurred regardless 
of post-weaning diet (control or high fat diet) [44]. This is particularly interesting as both 
studies used the same animal, high fat diet, study design, and method for determining 
whole body fat mass (as shown in Table 1) [44, 151]. The results from the study by 
Connor et al. suggest that high fat diet consumption post-weaning may impact female 
offspring body composition in adulthood (~4 months of age) greater than a maternal high 
fat diet [151]. This conclusion is consistent with the findings in the study by Sun et al. 
[17]. However, reasons as to why study findings of female offspring body composition 
differ in the studies by Howie et al. [44] and Connor et al. [151], despite having similar 
experimental designs, are unknown.  
The study by Elahi et al. confirms the finding of increased fat mass in female 
C57BL/6 mice at adulthood (9 months of age) from mothers fed a high fat diet (22% total  
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fat by weight - 18% lard, 4% soya oil) for 1.5 months plus during pregnancy and lactation 
[149]. Similar to the study by Howie et al. [44], this overall whole body fat mass 
remained higher in females from mother fed a high fat diet that also consumed a high fat 
diet post-weaning [149]. This study contradicts the conclusion from Connor et al. [151], 
and suggests that there may be programming in female offspring body composition at 
months of age due to maternal consumption of a high fat diet [149]. A similar study in 
C57Bl/6 mice by Devlin et al. [152] however, contradicts the study findings by Elahi et 
al. [149].  
The study by Devlin et al. is the only one to show lowering of fat mass in female 
offspring at adulthood (3.5 months of age), indicating no programming effect from 
maternal consumption of a high fat diet (22.5% total fat by weight – 19.5% lard, 3% 
soybean oil). However, female offspring were also studied until 6.5 months of age, at 
which point there were no differences in fat mass, indicating no programming effect from 
the maternal high fat diet [152]. These findings differ greatly from that of Elahi et al. 
[149], despite having the same experimental model, study design, and similar maternal 
high fat diet [149]. Females in the study by Devlin et al. may have lower fat mass at 3.5 
months of age due to a mismatch in caloric intake from the high fat diet consumed during 
gestation and suckling, to post-weaning control diet [152]. Female offspring may have 
initially had greater fat mass than females from mothers fed control diet, as they may 
have adapted to the increased energy supply. When diet was changed post-weaning to be 
lower in calories, the offspring may have lost fat mass as simply as a result of the caloric 
deficit. 
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Only two studies reported differences in female offspring whole body BMC, both 
of which differ in findings. Howie et al. found that maternal consumption of a high fat 
diet resulted in higher whole body BMC when compared to female Wistar rat offspring in 
adulthood from mothers fed control diet (~5 months of age) [44]. However, C57BL/6 
females from mothers fed a high fat diet for 1.5 months plus pregnancy and lactation had 
lowering of whole body BMC at 3.5 months of age, which was also sustained at 6.5 
months of age [152]. Results from the study by Devlin et al. [152] parallel previous 
literature in terms of the impact of direct high fat diet consumption, resulting in overall 
lowering of whole body BMC [51]. Additionally, it may be that female offspring from 
mothers fed a high fat diet in the study by Howie et al. [44] were able to effectively 
utilize the increased nutrient delivery provided by the high fat diet during gestation and 
suckling to promote optimal bone growth. It is shown that milk from mothers fed a high 
fat diet have a high level of protein [18], which is known to be imperative in supporting 
healthy bones [153]. It is difficult to determine whether maternal consumption of a high 
fat diet truly has a long-lasting impact on female offspring whole body BMC as the only 
two studies [44, 152] to investigate this have varying results. It may be important to 
determine overall whole body BMC in addition to changes in BMC at individual bone 
sites to determine whether a maternal high fat diet has an impact on whole body bone 
mineral accretion. 
Given the evidence provided above and detailed in Table 1, it is evident that a 
maternal high fat diet can contribute to long-lasting changes in female offspring body 
composition [44, 149, 151, 152]. Further investigation of the impact of a maternal high 
fat diet on female offspring body composition should be considered as there are multiple 
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inconsistencies in study findings. The particular components that may have contributed to 
discrepancies in studies will be discussed further in Section 3.4. It is of particular 
importance to examine whether there are long-lasting changes in female offspring body 
composition, given the rise in obesity in women of child-bearing age [154] and the 
increased predisposition of disease development with changes in maternal diet, as 
witnessed by the offspring of the Dutch winter famine [139, 143]. 
 
3.2. Effect of maternal high fat diet consumption on bone health in female rodent 
offspring – bone quantity, quality, strength, and fatty acid composition 
 Only two studies to date [58, 152] have investigated the effects of maternal high 
fat feeding on female offspring bone health. Methods and study design for these studies 
differ from each other, however the animal model and respective high fat diets used are 
similar [58, 152]. In the first study by Lanham et al., female C57BL/6 mice were fed a 
control or high fat diet (22% fat by weight – 18% lard, 4% soya oil) for 2.5 months, after 
which females were mated. Female mice continued to be fed the same respective diets 
throughout pregnancy and lactation [58]. It is important to note that the high fat diet had 
additional vitamins and minerals and protein added [58], to account for the greater 
content of fat, per energy basis. Female offspring from dams fed a control diet were 
weaned on the control or high fat diet, while offspring from dams fed a high fat diet also 
continued the high fat diet post-weaning until 7.5 months of age [58]. Femur density and 
structure were determined using µCT, and femur midpoint peak load measured by 
biomechanical testing (three-point bending). 
  
41 
 
This study is the only one to measure the effect of a maternal high fat diet on 
female offspring bone density. Lanham et al. found that femurs of females from mothers 
fed control diet and who were fed the high fat diet post-weaning had higher femoral 
density than females fed control diet post-weaning, from the same mothers. There were 
no differences in BMD between offspring fed a control diet, from mothers fed the same 
diet, and offspring fed a high fat diet from mothers fed the same diet [58]. However, 
femurs of female offspring fed a high fat diet post-weaning and born to control mothers, 
had the greatest trabecular spacing, which was significantly different from offspring 
exposed to control or high fat diets both in utero and post-weaning. There were no 
additional differences in bone volume fraction (bone volume/total volume ratio), 
trabecular thickness and number of trabeculae (per mm) among female offspring [58]. 
Despite these alterations in femoral trabecular structure, there were no differences in 
female offspring femur strength due to a maternal high fat diet [58]. Therefore, it is post-
weaning high fat diet consumption is more potent in modulating female offspring bone 
health in adulthood, compared to maternal high fat diet consumption. Femurs of female 
offspring fed a high fat diet post-weaning that were born to mothers fed control diet, may 
have been more susceptible to alterations in density and structure compared to femurs of 
females fed a high fat diet post-weaning from mothers fed the same diet as there was a 
mismatch in energy consumption from suckling to post-weaning.  Increased femoral 
BMD in these offspring may be a result of increased energy consumption as there was a 
greater level of nutrients available to support bone growth. Additionally, the energy level 
of protein, vitamins, and minerals were increased in the high fat diet. Therefore, offspring 
were receiving a greater level of calcium and vitamin D, which has been shown to be 
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imperative for optimal bone growth and development [155, 156]. However, offspring fed 
a high fat diet post-weaning born to mothers fed a control diet had increased trabecular 
spacing compared to offspring fed a post-weaning high fat diet from mothers fed the 
same diet. It may be that in elevated levels, dietary saturated fat intake post-weaning can 
be harmful to bone structure, rendering them weaker, which has been shown in previous 
studies [43, 57]. However, considering that female offspring fed a post-weaning diet from 
mothers fed a high fat diet did not have these adverse effects in femoral trabecular 
structure, it may be that offspring adapted to this level of fat in utero and suckling. This 
adaptation is also known as ‘predictive adaptive response’, which is developmental 
plasticity due to environmental factors in early life that prepare for the future 
environment [157]. However, the alterations in trabecular structure did not contribute to 
differences in bone strength, indicating that there is no increased potential of fracture risk 
due to a maternal high fat diet.  
The study by Lanham et al. tested bone strength solely in the femur, and despite 
determining structural differences amongst bone types (trabecular versus cortical), bone 
strength was only measured at a site of cortical bone (i.e. femur midpoint) [58]. Though 
clinically relevant, femurs are the load bearing bones in humans, therefore it may be 
important to understand the impact of a maternal high fat diet on other skeletal sites, such 
as vertebrae which are common sites of fracture in humans [158]. However, it is difficult 
to appropriately attribute any effects in offspring as a consequence of maternal high fat 
diet consumption as none of the dietary interventions isolated maternal high fat diet. For 
example, offspring from mothers fed a high fat diet were continued after weaning on the 
same high fat diet, making it difficult to decipher whether effects in offspring are due to 
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maternal or post-weaning high fat diet consumption. A dietary intervention that isolates 
the effects of the maternal high fat diet would have offspring being fed a healthy diet 
post-weaning. Therefore, although there are persisting effects on female offspring 
femoral density and structure, it may not be a result of the maternal high fat feeding, as 
offspring were also fed a high fat diet post-weaning. Therefore, this study may not truly 
demonstrate nutritional programming in female offspring bone health due to maternal 
high fat diet consumption.  
 The second study to examine the impact of maternal high fat diet consumption on 
female offspring bone structure and strength was conducted by Devlin et al. [152], who 
studied offspring at two time points, 3.5 and 6.5 months of age. Female C57BL/6 mice 
were fed a normal or high fat (23% total fat by weight – 20% lard, 3% soybean oil) diet 
for 6 weeks [152] (age of mice at onset of intervention is unknown). Mice were 
subsequently bred (12 – 18 weeks of age), and were continued to be fed their respective 
diets throughout pregnancy and lactation [152]. All offspring at weaning were fed a 
normal diet until 3.5 or 6.5 months of age. Femoral structure was determined with µCT, 
and femur midpoint peak load was measured by three-point bending through a materials 
testing system. At 3.5 months of age, female offspring from mothers fed a high fat diet 
had greater bone volume fraction (bone volume/total volume) compared to females from 
mothers fed a normal diet in distal femurs [152]. This effect however was diminished by 
6.5 months of age [152], indicating that trabecular bone structure in female offspring 
from mothers fed a high fat diet is not altered long-term. Additionally, there were no 
differences in femur midpoint peak load due to maternal high fat diet consumption [152].   
Differences in findings from Lanham et al. [58] and Devlin et al.[152] may be attributed 
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to post-weaning diet, as females from dams fed a high fat diet fed the same diet post-
weaning had greater trabecular spacing in femurs at 7.5 months of age in the study by 
Lanham et al. [58]. Whereas females from dams fed a high fat diet that were fed a control 
diet post-weaning had no differences in femur structure at 6.5 months of age in the study 
by Devlin et al. [152]. The finding of no differences in femoral midpoint peak load in this 
study is in accordance with the findings from Lanham et al., where despite changes in 
femoral trabecular structure, there were no differences in femur midpoint peak load [58, 
152]. However, only cortical bone was utilized for strength measurements. Considering 
the alterations in trabecular structure, it may be important to determine whether 
trabecular bone strength is impacted as a result. Like the study by Lanham et al. [58], it is 
evident that maternal high fat diet consumption does not alter female offspring femoral 
structure or strength, indicating no programming effect.  
 Although there are only two studies that have investigated the impact of a 
maternal high fat diet on female offspring bone health, the findings from these studies 
appear to be in accordance. Both studies [58, 152] used the same mouse model 
(C57BL/6), used similar high fat diets, methods for determining bone health, and studied 
offspring at similar ages. However the study by Lanham et al. [58]  increased the level of 
protein, vitamins, and minerals  to account for greater energy content in the high fat diet 
from the increased level of fat, which was not adjusted for in the study by Devlin et al. 
[152]. Even despite the lack of adjustment for protein, vitamins, and minerals, in the 
study by Devlin et al., any effect present at 3.5 months of age did not persist to 7.5 
months [152], indicating that a maternal high fat diet did not contribute to long-lasting 
changes in female offspring bone health. Furthermore, the study by Lanham et al. 
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demonstrate that a post-weaning high fat diet consumption is more potent in modulating 
female offspring bone health than a maternal high fat diet with post-weaning high fat diet 
consumption. This may be because offspring have become accustomed to the greater 
nutrient availability, and have adjusted their physiological responses accordingly.  
Further research in this particular area is needed, as there remain gaps in the current 
literature. Studies should consider increasing the levels of protein, vitamins, and minerals 
in the high fat diet, and have appropriate dietary interventions that allow for more 
suitable conclusions on whether maternal high fat diet consumption is the main 
contributor to observed effects in female offspring bone health. Additional research is 
required to determine whether trabecular bone strength is impacted due to maternal high 
fat diet consumption, as trabecular structure appears to be altered as a result [152]. No 
study to date has investigated whether maternal high fat diet consumption alters female 
offspring bone fatty acid composition. Though it is established that bones are particularly 
sensitive to dietary fatty acids as discussed previously [63, 73, 74], it is not known 
whether fatty acid composition changes when high fat diet exposure occurs solely in the 
previous generation. This information, in addition to measurements of bone mineral, 
quantity, and strength, will provide a more extensive profile on overall bone health. 
Furthermore, the role of changing fatty acids in bone and its functional effects on strength 
require greater characterization. This may be functionally important to determine relative 
fracture risk or predisposition of developing osteoporosis later in life, as a consequence of 
early life exposure to maternal over-nutrition. 
 
  
47 
 
3.3. Effect of maternal high fat diet consumption on female offspring plasma 
hormone concentrations in rodents 
 Hormone levels are often reflective of overall health status. Individuals with a 
disease will have similar hormonal profiles that reveal underlying health problems. For 
instance, individuals with metabolic syndrome are typically obese [159], and will have 
elevated levels of pro-inflammatory cytokines [159-161]. This is reflective of the level of 
adiposity, which is responsible for the secretion of these cytokines [90, 96]. It is 
important to study hormones in female offspring to determine whether their hormone 
profiles are indicative of underlying diseases. 
 
3.3.1. Leptin 
 Few studies in animal models have investigated whether a maternal high fat diet 
can alter circulating levels of leptin in female offspring. The majority of these studies 
have indicated no differences in leptin concentrations due to maternal high fat feeding 
[17, 44, 151, 162, 163], all of which have varied duration of exposure to maternal diet, as 
well as type, and quantity of fat used in maternal diet. Some studies have focused on 
whether maternal diet during pregnancy-only modulates offspring phenotype, or whether 
post-natal diet is a contributor to this. Female offspring rats from dams fed a high fat diet 
throughout pregnancy and lactation had higher leptin levels than offspring from dams fed 
a high fat diet solely in pregnancy. This is a clear indication that a post-natal high fat diet 
exposure from dam’s milk during lactation can indeed alter female rat offspring leptin 
levels in early life (PND10, PND12, PND21) [17, 44, 163]. Howie et al. also found that 
elevated leptin levels in females from dams fed a high fat diet (for 3.5 months plus 
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pregnancy and lactation; or solely during pregnancy and lactation) are sustained into 
adulthood (5.5 – 6 months of age) even with a control diet post-weaning. Furthermore, 
leptin levels were also positively correlated with fat mass in female offspring [44], which 
corresponds to the literature regarding leptin and adiposity [80].  
 Two studies in particular contradict the findings of Howie et al. [44]. Connor et 
al. used the same model (Wistar rat) and high fat diet (24% fat by weight – 21% lard, 3% 
soybean oil)  as Howie et al. [44]. High fat diet exposure occurred solely during 
pregnancy and lactation, and female offspring from dams fed the high fat diet had no 
differences in fasted plasma leptin at 4 months of age [151]. It is not clear why 
differences in results occur in this study by Connor et al. [151] compared to the study by 
Howie et al. [44], considering both studies had the same experimental model, dietary 
intervention and method of determining plasma leptin concentrations in female offspring. 
Differences in results may be attributed to the lack of increased fat mass in female 
offspring from dams fed a high fat diet in the study by Connor et al. [151], which was a 
factor in female offspring in the study by Howie et al. [44].  
A study by Férézou-Viala et al., [162] also contradicted the findings from Howie 
et al. [44]. Wistar rat dams were fed a high fat diet (40% total fat by weight – 38% palm 
oil, 2 % colza oil) for 6 weeks plus pregnancy and lactation, found that control-fed 
female offspring (~2 months old) from dams fed a high fat diet had no differences in 
fasting plasma leptin concentrations. Discrepancies from the study by Howie et al., [44] 
may be due to the duration of maternal high fat feeding, and not necessarily the amount 
of fat used in the dietary intervention. After reviewing the current literature, a definitive 
conclusion remains to be established regarding the impact of a maternal high fat diet on 
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female offspring leptin concentrations. Future investigations in this area of research 
should consider discovering the specific quantity of fat needed and the appropriate 
duration of maternal exposure to a high fat diet. This will help better understand the 
precise situations in which female offspring are predisposed to higher leptin levels, and 
subsequent risk of disease development in later life. 
 
3.3.2. Tumour Necrosis Factor-Alpha 
 A study by Pantaleão et al. is the only to examine the impact of a maternal high 
fat diet on female offspring TNF-α levels [163]. Wistar rat dams were fed a high fat diet 
(40% fat by weight – 33% lard, 7% soybean oil) or control diet for 10 days prior to 
conception, as well as during pregnancy. Dams were fed either control or high fat diet 
after parturition throughout lactation. There were no differences in serum TNF-α 
concentrations in weanling female offspring (3 weeks old) from either dietary 
intervention (i.e. maternal high fat or control diet; post-weaning high fat or control diet) 
[163]. This study further provides evidence that a maternal high fat diet during pregnancy 
may not elicit changes in inflammation measured by TNF-α in female offspring at 
weaning. A lack of effect by the maternal high fat diet may be due to exposure time of 
the diet as dams assigned the high fat diet only began consumption days before 
conception, and were either kept on the same diet or were switched to a control diet at 
parturition [163]. The duration of maternal high fat diet in this study may not have been 
adequate to elicit programming in dams, which may have further exacerbated the effects 
of the high fat diet on female offspring TNF-α concentrations. Perhaps high fat diet 
consumption at different stages of pregnancy (e.g. early, mid, late gestation) would elicit 
  
50 
 
programming various effects in offspring. This hypothesis was observed in offspring 
from mothers exposed to the Dutch winter famine, whereby offspring exposed to famine 
in early gestation had greater risk of disease development than offspring exposed to 
famine in mid and late gestation [143]. Further studies are required to appropriately 
establish the conditions in which a maternal high fat diet can alter female offspring TNF-
α concentrations. This will help determine the level of systemic inflammation in female 
offspring as a result, and disease risk as a consequence. 
 
3.3.3. Interleukin-6 
 The effects of a maternal high fat diet on female offspring IL-6 levels are 
currently not well characterized. The few studies that have measured IL-6 levels in 
female offspring have examined mRNA expression in tissues such as the brain [164] and 
liver [165] as indicators of inflammation or dysfunction of the specific tissue. One study 
in humans examined plasma IL-6 concentrations in offspring, where offspring born to 
mothers who gained more weight during pregnancy than recommended had higher IL-6 
concentrations than offspring from mothers that gained weight within the recommended 
range. Gestational weight gain in this study [166] was not measured as a result of high fat 
diet consumption, however if pregnant women consumed foods higher in dietary fat, an 
elevated weight may be achieved which could correlate to higher IL-6 levels, however 
this is an indirect speculation [166]. It is important to measure levels of systemic 
inflammation in offspring in response to a poor maternal diet to determine whether 
offspring are predisposed to associated health complications later in life. 
 
  
51 
 
3.3.4. MCP-1 
 There are currently no studies to date that have examined the impact of a maternal 
high fat diet on female offspring MCP-1 concentrations. This is an important area of 
discovery as MCP-1 is a known promoter of chronic inflammation commonly observed 
in obesity [105]. Determining whether offspring from mother’s fed a high fat diet have 
higher levels of MCP-1 throughout life may be beneficial for understanding the 
offspring’s risk of other chronic illnesses potentially as a result of a poor maternal diet. 
This is especially important with the increase prevalence of obesity in women of child-
bearing age [154], and greater consumption of saturated fats due to the Western diet [33]. 
 
3.3.5. 17β-Estradiol 
 Little is known on the effects of a maternal diet high in saturated fat on female 
offspring estradiol levels. This may be important to determine as estradiol is imperative 
for proper bone formation [111]. Furthermore, higher levels of estradiol due to maternal 
diet can predispose female offspring to breast cancer development [167]. This was 
demonstrated in studies which fed mothers a diet high in n6 polyunsaturated fats, which 
are known to raise estradiol levels [167-169]. It is important to measure levels of 
estradiol in female offspring to determine whether a maternal high saturated fat diet can 
permanently alter levels of estradiol and relative risk of disease later in life. 
 
3.3.6. Progesterone 
 Two studies have directly measured progesterone levels in female offspring born 
to mothers fed a high saturated fat diet, all of which are in animals models. Both studies 
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used a similar design, with the same model and high fat diet intervention [151, 170]. 
Female Wistar rats were fed a high fat (21% lard, 3% soybean oil by weight) or control 
diet for life (from weaning until ~2.5-3 months), as well as throughout pregnancy and 
lactation [151], or solely during pregnancy and lactation [170]. There were no differences 
in plasma progesterone concentrations in female offspring at ~4 and 5 months of age due 
to life-long maternal high fat feeding [170]. However, these two studies have conflicting 
results in female offspring progesterone concentrations when maternal high fat diet 
exposure is restricted to pregnancy and lactation. Sloboda et al. show that ~5 months old 
female offspring from dams fed a high fat diet, fed control diet post-weaning, had higher 
progesterone levels than control-fed offspring from dams fed a control diet (throughout 
pregnancy and lactation). A post-weaning high fat diet did not contribute to any 
additional alterations in female offspring plasma progesterone concentration [170].  
Conversely, Connor et al. show that a maternal high fat diet occurring throughout 
pregnancy and lactation did not alter female offspring plasma progesterone 
concentrations at ~4 months of age, regardless of post-weaning diet (i.e. control or high 
fat) [151]. It is unclear why these two very similar studies have conflicting results. 
However, with the lack of studies in this area of research, it is difficult to provide a 
definitive conclusion regarding the influence of a maternal high fat diet on female 
offspring progesterone concentrations. It is unknown whether diets that contain a greater 
or lesser amount of fat will have a similar impact on female offspring progesterone 
concentrations. This may be an important area of future research as progesterone is a 
known modulator of fat mass distribution and bone health in females [126], and changes 
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in levels of progesterone may lead to fat mass accumulation in areas associated with 
disease development [113], as well as potential dysfunction in bone remodelling. 
 
3.4. Knowledge gaps 
The literature in previous sections describes the impact of maternal high fat diet 
consumption on female offspring body composition, bone health, and hormone 
concentrations. The discrepancies in study findings are difficult to appropriately compare 
and contrast as there are inherent differences in experimental designs of most studies. 
Some of the key differences that may have impacted the inconclusiveness of study 
findings are: experimental models, quantity of fat supplied in the high fat diet, age of 
offspring studied, and level of protein and micronutrients in the high fat diet. Detailed 
discussion of the key differences among studies are the following: 
 
i. Differences in the experimental model used amongst studies. Although all of the 
studies described above used rodents, there were differences in strains used. More 
specifically, three different strains of rodents were used amongst studies: Wistar rats, 
Sprague Dawley rats, and C57BL/6 mice. In regards to the literature, rats were more 
resistant to changes in body composition compared to C57BL/6 mice. These mice had 
evident changes in body composition (i.e. increased fat mass, lower lean mass) due to 
maternal consumption of a high fat diet [149, 150]. However, rats with similar changes in 
body composition had also consumed a post-weaning high fat diet [17, 151], which may 
have exacerbated the sole effects of the maternal high fat diet. Though the literature 
regarding programming of bone health has only been investigated in C57BL/6 mice, it 
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may be important to determine whether these same effects are evident in other species, 
specifically rats, as these are the preferred model for examining osteoporosis and bone 
health [171].  
Although these rodents are the preferred models when using a high fat diet (due to 
the responsiveness to diet-induced obesity [48]), there may be specific strain differences 
that could impact the sensitivity of the rodent to the high fat diet, or relative resistance to 
the development of health complications as a result. Furthermore, changes in growth rate 
between species may also differ (i.e. mice versus rats), which could impact overall 
metabolism and rate of bone mass accretion.  
 
ii. The quantity of fat used in the dietary interventions is inconsistent among studies. 
The quantity of fat amongst studies discussed in the literature has greatly varied. Some 
studies reported using a diet containing as high as 40% fat by weight [17, 150], while 
others used a diet containing 22% fat by weight [149, 152]. Generally, studies in which 
offspring were fed a healthy diet post-weaning found similar alterations in female 
offspring body composition (i.e. increases in fat mass, lower lean mass) [44, 149, 150]. 
However the minimum quantity of fat required in the maternal diet that is required to 
elicit these changes in female offspring body composition occur is unknown. A higher 
level of fat in the maternal high fat diet) may have induced further changes in female 
offspring compared to studies using a lower level of fat. For example, a diet that has a 
higher quantity of fat (40% fat by weight [17, 150]) may induce obesity in mothers, 
which may therefore predispose offspring to become obese as well [172], compared to 
offspring from mothers fed a diet with a lower fat content (22% fat by weight [149, 152]). 
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However, the two studies that implemented a diet with 40% fat by weight studied 
offspring at a young age (day of birth [150] and weaning [17]), therefore it is difficult to 
compare findings to other studies that used lower quantities of fat and examined offspring 
in adulthood.  
Although the two studies that investigated female offspring bone health had diets 
containing a similar level of fat in the maternal diet, there are differences in results. 
Offspring in the study by Lanham et al. [173] had greater femoral density, and increased 
trabecular spacing. However, Devlin et al. [152] found no differences in offspring bone 
health due to maternal consumption of a high fat diet. Despite similar quantities of fat in 
the experimental diets, it is difficult to appropriately compare and contrast these study 
findings as offspring were fed different post-weaning diets. The quantity of fat in the high 
fat diet may dictate the severity of health complications in offspring, and whether these 
complications are truly long-lasting, indicative of programming. 
 
iii. The age at which offspring were studied differed among studies. Most studies have 
examined female offspring during adulthood [44, 149, 151, 152, 173], a time in which 
growth is slow. It may be particularly important to highlight changes in female offspring 
body composition and bone health at different stages of life, particularly in periods of 
rapid growth and development (i.e. early life), and stages of slower growth (i.e. 
adulthood). This can help decipher whether any changes that exist in early life truly 
remain persistent in adulthood, which would suggest programming.  
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iv. Post-natal or post-weaning diet consumption of offspring. In reviewing the literature, 
it is evident that offspring fed a post-natal or post-weaning high fat diet had greater 
changes in body composition (i.e. increased fat mass, lower lean mass) [17] than those 
fed a healthier diet [44, 151, 152]. Furthermore, female offspring that consumed a high 
fat diet post-weaning had greater changes in bone health (i.e. increased femoral density, 
cross sectional area, trabecular spacing) [173], whereas offspring fed a healthy diet found 
no changes in bone due to maternal high fat diet consumption [152]. In order to 
appropriately attribute any changes in offspring body composition to maternal 
consumption of a high fat diet, it is important for offspring to consume a healthy diet 
postnatally and/or post-weaning. If offspring are continued on the same high fat diet as 
their mother’s throughout life, it would be impossible to determine whether any 
differences in body composition and/or bone health were due to exposure of the maternal 
diet or the post-weaning diet. 
  
v. Level of protein, vitamins and minerals in the high fat diet. Only one study that 
examined female offspring body composition (Elahi et al. [149]) and only one study that 
examined female offspring bone health (Lanham et al. [58]) in the literature described 
previously increased the level of proteins, vitamins, and minerals in the maternal high fat 
diet. It is important to increase the level of protein, vitamins, and minerals in the high fat 
diet as overall energy has increased. It is well documented that calcium and vitamin D are 
imperative for optimal bone growth [174, 175] and maintenance [176, 177]. Studies also 
show importance for adequate protein intake as low dietary protein consumption in rats 
causes impaired bone formation [178], and increases risk of fracture in the elderly [179, 
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180]. The elevation of these important nutrients would ensure that appropriate levels of 
each nutrient would be maintained, per energy basis. This is to ensure that any persistent 
changes evident in female offspring body composition and/or bone health could 
appropriately be attributed to the level of fat in the diet, rather than insufficient intake of 
these nutrients.  
After reviewing the literature and the apparent inconsistencies amongst studies, it 
is important for research to continue in the area of maternal high fat diet consumption and 
its impact on female offspring body composition and bone health. This research would 
help bridge gaps in current discrepancies in findings from the literature.  
 
Chapter 4.0: Objectives and Hypotheses       
The overall objective of this work was to determine if long-term maternal high 
saturated fat (HSF) feeding, as well as throughout pregnancy and lactation, had adverse 
effects on body composition and bone health in female offspring in a Wistar rat model. 
The Wistar rat is an established model for high fat feeding, as this model develops 
chronic diseases (obesity, glucose intolerance) similar to how humans react upon long-
term consumption of a high fat diet [48]. This rat model is also an established model for 
the study of osteoporosis and its prevention [171]. The rat is a suitable experimental 
model to examine human bone growth and development patterns are similar. Particularly, 
after rapid growth in rats, where peak bone mass is attained at 10 months of age [181, 
182], bone remodelling is favoured over bone modelling, as occurs in humans [183].  
Plasma hormones were measured as subsequent markers of metabolic status and 
additional contributors to alterations in body composition and/or bone homeostasis.  
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Specific objectives were to determine the effect of maternal exposure to a HSF diet on 
female offspring for the following outcomes: 
i. Body composition – lean, fat and bone mass, as well as fat mass distribution; 
and  
ii. Bone health – specifically bone quantity (BMC, BMD) and strength (peak 
load) in femurs and lumbar vertebrae, and femur fatty acid composition.  
Each of the above mentioned objectives were examined in female offspring only. 
Knowing that programming effects may be evident over generations due to epigenetic 
modifications, it is important to study effects in female offspring. This is because any 
effect that occurs in female offspring may transfer to their offspring [139, 145-147]. All 
female offspring were studied at two time points: weaning and three months. It is 
important to study offspring in early life (weaning) and young adulthood (3 months of 
age) to determine whether any apparent alterations in body composition or bone health at 
weaning (when offspring are still suckling) persist into adult life; a persistent effect 
would be indicative of programming due to maternal diet. 
In accordance with the specific objectives, we hypothesized that female offspring 
of dams fed a HSF fat diet at weaning and three months of age would have: 
 Lower lean and bone mass, with higher fat mass 
 Greater fat accumulation in visceral fat pads compared to subcutaneous fat pads, 
indicating metabolic distress 
 Lower BMC and BMD in both femurs and lumbar vertebrae 
 Higher saturated fatty acid content in femurs 
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 Lower peak load in femurs and lumbar vertebrae  
 
Chapter 5.0: Study Design       
All experimental procedures were approved by the Brock University Animal Care 
Committee, and complied with the Canadian Council on Animal Care [184]. Female 
Wistar rats (n = 23) were obtained at weaning (~28 days old) and housed two per cage 
with a 12:12 hour light/dark cycle. Rats were housed two per cage for environmental 
enrichment, and to ensure rats had reduced anxiety and neural deficits, as rats in isolation 
often demonstrate [185]. Rats were randomly assigned to receive one of two diets; a 
control (AIN93G diet, 7% soybean oil by weight) or HSF diet (modified AIN93G diet, 
20% lard by weight) ad libitum for 10 weeks starting at 1 week post-weaning (28 days of 
age). The CON diet contained 18.8% protein, 63.9% carbohydrate, and 17.2% energy 
from fat (TD.94045; Harlan Teklad, Mississauga, ON). The HSF diet contained 19.1% 
protein, 39.9 % carbohydrate, and 41.0% energy from fat (TD.02016; Harlan Teklad). 
Both the type and quantity of dietary fat were altered in the HSF diet compared to CON 
diet. This was done to best represent the typical dietary fat consumption as observed in 
the modern Canadian diet, which is associated with elevated intake of foods rich in 
saturated fat (i.e. red meat) [186]. The amount of protein, vitamins, and minerals in the 
HSF diet were increased by a factor of 1.2 compared to the control diet to match the 
increased energy content (3.8 kcal/g CON diet versus 4.4 kcal/g HSF diet) (Table 3). This 
was done to ensure that any observed effects in offspring can be attributed to the higher 
level of fat in the diet, and not due to a lower relative energy intake of these nutrients. As 
the level of fat increases, the relative energy contribution of proteins and micronutrients 
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is lowered as a result. Therefore, the level of protein and micronutrients were increased 
by the same factor per kg of diet as the dietary fat to ensure the relative contribution of 
these nutrients was similar to that of a healthy diet. Food intake was measured three times 
a week using an electronic scale (VI-1200, Acculab, Bradford, MA, USA). Food intake 
was determined by weighing, recording, and subtracting the amount of food remaining by 
the new food provided in one cage for that day. To account for the number of rats in a 
cage, the total food intake per cage was divided by 2 (2 rats per cage). Although pair 
feeding would appropriately control for energy intake amongst dietary conditions, 
individuals that habitually consume a HSF diet may also consume above their daily 
caloric requirements. Therefore to best represent the dietary pattern of the Canadian diet 
(where 50% of women and 70% of men consume above their daily caloric requirements 
[187]), energy consumption amongst dietary groups was not controlled for. Body weights 
were recorded weekly using an electronic scale (VI-1200, Acculab).  
After 10 weeks of feeding, females were bred with male Wistar rats (n = 6) of 
similar age. Each male rat was bred with the same number of females from each 
intervention to ensure equal paternal influence among groups. Males were placed in a 
cage of female rats until successful mating (~ 1 week), which was established in females 
by an increase in body weight greater than normal weekly weight gain (as determined by 
female Wistar rat growth chart). After pregnancy confirmation, female rats were 
continued on their assigned diets throughout pregnancy and lactation. Offspring were 
weaned at PND 19. Dams were fasted overnight and euthanized the following morning 
by an overdose of sodium pentobarbital (12 mg/100 g body weight). Blood, bones 
(femurs and lumbar vertebrae), and fat pads (retroperitoneal, omental, gonadal) were 
  
61 
 
collected. Two male and 2 female offspring per litter were euthanized at weaning – 1 
male and 1 female were used for body composition measurements, while the other male 
and female from the litter were used for tissue collection (blood, bones, organs, fat pads).  
Additionally, 2 males and 2 females per litter were weaned onto CON diet and 
studied until 3 months of age. Offspring weaned to CON diet were selected by body 
weight; where 2 female and 2 male offspring with the median body weights (in the range 
of body weights of all female or all male offspring per litter) were selected. Food intake 
was measured 3 times per week, while body weight was recorded once weekly from 
weaning to 3 months of age. To ensure no “litter effect” (“litter effect” refers to the fact 
that siblings will have more similar characteristics than offspring who are not siblings,  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Flow chart depiction of the study design 
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and thus including more than one offspring per sex per litter may influence findings by 
over-representation of a specific characteristic) [188], only 1 male and 1 female per litter 
were reported for each outcome.  
 
Table 3. Dietary composition of experimental diets 
Ingredient CON HSF 
Soybean oil (g/kg) 70 - 
Lard (g/kg) - 200 
Casein (g/kg) 200 240 
L-Cysteine (g/kg) 3 3.6 
Corn starch (g/kg) 397.49 217.38 
Maltodextrin (g/kg) 132 132 
Sucrose (g/kg) 100 100 
Cellulose (g/kg) 50 50 
Vitamin mix (AIN93G-VX) (g/kg) 10 12 
Mineral mix (AIN93G-MX) (g/kg) 35 42 
   
Quantity of vitamins and minerals   
Calcium (g/kg) 5.04 6.05 
Phosphorus (g/kg) 2.96 3.55 
Magnesium (g/kg) 0.51 0.62 
Folic acid (mg/kg) 2 2.4 
Vitamin A (IU/kg) 4000 4800 
Vitamin D (IU/kg) 1000 1200 
Vitamin E (IU/kg) 75 90 
Vitamin K (mg/kg) 0.75 0.9 
   
Energy contribution of nutrient  
(% kcal) 
  
Fat 17.2 41 
Protein 18.8 19.1 
Carbohydrate 63.9 39.8 
   
Relative quantity of nutrients 
(% by weight) 
  
Fat 7.2 20.2 
Protein 17.7 21.2 
Carbohydrate 60.1 44.2 
             CON – AIN93G (TD.94045; Harlan Teklad); HSF – modified AIN93G  
               (TD.02016; Harlan Teklad) 
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     Table 4. Fatty acid composition of experimental diets 
Fatty acid CON HSF 
14:0 0.59 ± 0.01 2.31 ± 0.03 
16:0 12.25 ± 0.10 25.79 ± 0.03 
18:0 4.19 ± 0.02 11.95 ± 0.21 
16:1 0.20 ± 0.01 2.75 ± 0.01 
18:1 20.42 ± 0.36 36.34 ± 0.17 
18:3n3 8.46 ± 0.06 0.82 ± 0.01 
18:2n6 51.91 ± 0.31 16.38 ± 0.29 
Total SFAs 18.52 ± 0.10 41.67 ± 0.12 
Total MUFAs 21.01 ± 0.36 40.10 ± 0.21 
n3 PUFAs 8.46 ± 0.06 1.10 ± 0.01 
n6 PUFAs 52.00 ± 0.30 17.14 ± 0.29 
Values are expressed as percent mole fraction of total fatty acids, percent 
mole fraction of fatty acids below 1% for both diets are not shown; CON, 
AIN93G diet; HSF, AIN93G with 20% lard by weight; SFA, saturated 
fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated 
fatty acid. 
 
At 3 months of age, similar to weaning, 2 male and 2 female offspring per litter 
were euthanized with an overdose of sodium pentobarbital after an overnight fast. One rat 
per gender was used for body composition measurements while one rat per gender was 
used for tissue collection (same as dams and weanling offspring). All blood samples, 
excised bones, and half of the sampled fat pads (per rat) were stored at -80°C until 
analyses. The other half of sampled fat pads were stored in scintillation vials containing 
10% formalin (buffered neutral), and archived. It is important to note that subsequent 
outcomes in this study were conducted solely in female offspring; male offspring were 
examined in a separate study. 
 
Chapter 6.0: Methodology   
6.1. Distribution of adipose tissue 
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The distribution of adipose tissue was determined by individual extraction and 
weighing of fat pads. Fat pads were sampled at 3 different sites: omental, retroperitoneal, 
and parametrial. Fat pads were carefully excised in dams and female offspring (weaning 
and 3 months of age) after euthanasia, and weighed on an electronic scale (VI-1200, 
Acculab). Individual, as well as the sum of all fat pads collected, were compared. Fat pad 
comparisons between groups examined differences in absolute and relative weights. 
Relative weights were calculated by adjusting for body weight. Relative fat pad masses 
were calculated as follows: fat pad mass (g) / body mass (kg). 
 
6.2. Body composition assessment 
  Body composition (lean, fat and bone mass) was determined using DXA (pSabre, 
Orthometrix, Naples, FL, USA) and specialized software (Host Software version 3.9.4; 
Scanner Software version 1.2.0)  at weaning and 3 months of age. All rats were 
anaesthetized with isofluorane, and placed on the scanning field in a prone position (nose 
facing left side of scanning field) prior to analysis. In weanling females, the region of 
interest (ROI) surrounded the abdominal region (4 cm in width, 3.5 cm in height), with 
the lower boundary immediately above the femurs heads [189] and scan parameters of 10 
mm/s (speed) and a resolution of  0.2 x 0.2 mm. Three month old offspring were scanned 
with the ROI 10 cm in width and 7 cm in height, fixed in the abdominal region, again 
with the lower boundary immediately above the femur heads [189] and scan parameters 
of 10 mm/s (speed) with a resolution of 0.5 x 1.0 mm. Percent lean, fat, and bone mass 
were calculated by dividing lean, fat, or bone mass in grams by the total mass of the ROI 
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and multiplying by 100. Coefficients of variation for weanling female offspring % bone 
mass, % lean mass, and % fat mass were as follows: 6.7%, 1.8%, and 9.7%. 
 
6.3. Collection of plasma and hormone analysis 
Blood was collected in EDTA tubes and centrifuged at 3000 RPM for 10 minutes 
at 4°C to obtain plasma from dams and female offspring (weaning and 3 months of age). 
Multiplex immunoassays for metabolic hormones were completed using Magpix 
technology with xPONENT software (Luminex Corporation, Austin, TX, USA). Plasma 
from dams and all female offspring were measured for leptin, TNF-α, IL-6, and MCP-1 
using a Rat Metabolic Magnetic Bead Panel (Cat. #RMHMAG-84K; Millipore 
Corporation, Billerica, MA, USA). Plasma from dams and 3 month old females were 
measured for 17β-estradiol and progesterone using a Steroid/Thyroid Hormone Magnetic 
Bead Panel (Cat.#STTHMAG-21K; Millipore Corporation). Samples were pipetted (25 
µL) in a 96-well plate in triplicate along with quality controls and standards in buffer. 
The plate was incubated (in the dark) with antibody immobilized beads at 4ºC on a shaker 
(low speed) overnight. After washing samples, detection anitbodies (50 µL) were added 
and incubated on shaker (30 minutes in the dark), followed by another incubation (30 
minutes in the dark) with the addition of Streptavidin-Phycoerythrin (50 µL) before 
running the plate. 
Unlike the Metabolic Magnetic Bead Panel, samples for the Steroid/Thyroid 
Hormone Magnetic Bead Panel were prepped with acetonitrile precipitation. Acetonitrile 
(375 µL) was added to samples, vortexed (~5 seconds) and left to settle for 10 minutes. 
Samples were vortexed again (~5 seconds), and subsequently centrifuged for 5 minutes at 
  
66 
 
17000 g. Five hundred microliters of supernatant was removed from each sample, and 
dried using a refrigerated Speed Vac (Refrigerated CentriVap Concentrator, Labconco, 
Kansas City, MO, USA) on the highest vacuum setting. Dried samples were reconstituted 
in buffer (200 µL) and placed on a shaker for 10 minutes. The immunoassay protocol is 
similar to the Metabolic panel kit described above, with the addition of horseradish 
peroxidase conjugate (25 µL) to each of the wells before the addition of antibody 
immobilized beads, with an overnight incubation on a shaker at 4ºC (in the dark) 
following. Twenty-five microliters of detection antibody was added to the plate, sealed, 
covered and agitated (low speed) for 1 hour. Twenty-five microliters of Streptavidin-
Phycoerythrin was added to each well, agitated (low speed) for 30 minutes, and 
subsequently washed. The plate was run with buffer using the same software as described 
above.  
 
6.4. Bone quantity of excised femurs and LV1-3 
 Bone quantity of femurs and lumbar vertebrae 1-3 (LV1-3) was measured as 
BMC (mg) and BMD (mg/mm
2
) in dams and female offspring (weaning and 3 months of 
age) using DXA (pSabre, Orthometrix) and specialized software (host software version 
3.9.4; scanner software version 1.2.0) [63]. Since offspring at weaning are still growing, 
BMC was adjusted for the length of the femur during analysis. Right femurs were 
scanned as a whole, and additionally at the 1/3
rd
 proximal end as there is more trabecular 
bone at this site. The 1/3
rd
 proximal femur is also the site at which a hip fracture would 
occur (femur neck) in humans. Femurs were placed on the scan field in the upper right 
quadrant, with the distal femur at the vertical axis, laid on its posterior surface (femur 
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head facing the operator). The 1/3
rd
 proximal femur was determined by dividing the 
length of the whole femur by 3, and placing an additional ROI with the calculate length at 
the proximal end. LV1-3 was also positioned in the upper right quadrant laid on its 
spinous processes, with LV3 proximal to the vertical axis. The femurs and LV1-3 from 
weanling offspring were scanned at a speed of 2 mm/sec and a resolution of 0.1 x 0.1 
mm. Coefficients of variation for BMC of the whole femur and LV1-3 in weanling 
females are: 2.4% and 5.2%. Coefficients of variation in weanlings for BMD of the 
whole femur and LV1-3 are: 4.6% and 1.7%. Femurs and LV1-3 from dams and 3 month 
female offspring were analyzed at a speed of 10 mm/sec, and a resolution of 0.2 x 0.2 
mm. Coefficients of variation in BMC of the whole femur and LV1-3 in 3 month old 
female offspring were: 0.2% and 1.3%. Coefficients of variation in 3 month old female 
offspring for BMD of the whole femur and LV1-3 were: 0.3% and 0.6%, respectively. 
 
6.5. Biomechanical strength of femurs and LV3 
Bone strength in femurs and LV3 of dams and 3 month old female offspring was 
determined as peak load, which is the maximum force a bone can withstand before 
fracturing. Peak load was measured at the femur midpoint, femur neck, and 3
rd
 lumbar 
vertebrae using a materials testing system (Model 4442, Instron, Norwood, MA, USA) 
and specialized software (Series IX Automated Materials Tester, version 8.1 5.00, 
Instron). To determine peak load at femur midpoint, the femur was laid on its posterior 
surface on two metal holders spaced ~14 mm apart. A stainless steel crosshead was 
lowered perpendicularly to the femur at a constant speed of 2 mm/min, until peak load 
was achieved (i.e. fracture). Once the femur fractured, the proximal end of the femur was 
  
68 
 
placed in a customized jig that allowed the femur to be fixed in a vertical position (femur 
head facing up). The stainless steel crosshead (with a flat, circular surface) was lowered 
at the same speed, perpendicular to the femur neck until fracture. To determine peak load 
of LV3, LV3 was fixed upright on a metal custom jig with a circular, flat surface. The 
crosshead (the same the custom jig) was slowly lowered at 2 mm/min which 
subsequently compressed the vertebra until fracture [63]. Peak load was quantified (in 
Newtons) by observing the highest peak from the load-displacement curve generated 
from software. 
 
6.6. Lipid composition in femurs 
Lipid composition of left femurs from dams and female offspring (weaning and 3 
months of age) was determined in cortical bone. Femurs were sliced in half using a band 
saw. Bone marrow was discarded and fragments of bone were wrapped in aluminum foil 
and placed in liquid nitrogen. The bone fragments were hammered and then pulverized 
using a mortar and pestle under liquid nitrogen [190]. The resultant powder was added 
into 15 mL glass screw cap Kimax tubes and total lipids were extracted with 2:1 
chloroform:methanol [191]. Extracted lipids were dried under nitrogen, weighed, and 
reconstituted in 2 mL of chloroform to form the lipid stock. Total lipid from each sample 
was saponified and methylated [190]. Briefly, 0.0625 mg of lipid from each lipid stock 
was saponified and methylated at 100 °C using 0.5 M of potassium hydroxide and 6% 
H2SO4-MeOH, respectively. The resulting fatty acid methyl esters were separated on a 
UFM-RTX WAX analytical column (Thermo Electron Corp., Milan, Italy) using gas 
chromatography (Trace GC Ultra, Thermo Electron Corp.) fitted with a fast flame 
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ionization detector, a split-splitless injector, and Triplus AS autosampler [30]. Fatty acids 
were identified by comparison of retention times with those of a known standard 
(Supelco 37 component FAME mix, Supelco, Bellefonte, PA, USA) and absolute 
amounts of individual fatty acids were calculated with the aid of an internal standard, 
tridecanoic acid (13:0), added to the samples prior to methylation.  
 
6.7. Statistical analyses 
All statistical analyses were completed using SigmaStat (version 3.5, Systat, 
Chicago, IL, USA). For dams, independent samples t-tests were used for body weight (at 
breeding and 6 months of age), fat pad mass (absolute and relative to body weight), 
plasma hormones (leptin, TNF-α, IL-6, MCP-1, 17β-estradiol, progesterone), bone 
mineral (femurs and LV1-3), bone strength (femur and LV3), and femur lipid profile. A 
repeated measures ANOVA followed by a Student-Newman Keul’s (SNK) post-hoc 
analysis, was used to determine food intake in dams.  For female offspring, a repeated 
measures 2-way ANOVA, followed by SNK post-hoc analysis was used to analyze body 
weight and food intake, with offspring age and maternal diet used as the two factors. 
Offspring body composition (lean, fat, and bone mass expressed as % of ROI), fat pad 
weights (retroperitoneal, omental, parametrial), plasma hormones (leptin, TNF-α, IL-6, 
MCP-1, 17β-estradiol, progesterone), bone mineral (femurs and LV1-3), bone strength 
(femur and LV3), and femur lipid profile were analyzed using 2-way ANOVA with SNK 
post-hoc analysis. Independent samples t-tests were conducted for litter comparisons 
(litter number, male:female ratio, weight), as well as 17β-estradiol and progesterone 
levels as there was only sufficient quantity of sample for measurement at 3 months of 
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age. Independent samples t-tests were also used to conduct bone strength in female 
offspring at 3 months of age as bones at weaning were too small for the strength analyses. 
Data are expresses as mean ± SEM. Statistical significance was determined at p ≤ 0.05.  
 
Chapter 7.0: Results 
7.1. Litter characteristics 
 There were no differences in litter size, or litter weight at PND3. Differences in 
litter weight were detected at PND12 and weaning (PND19) where offspring from dams 
fed the HSF diet were heavier than those from dams fed CON diet (Table 5).  
 
 
Table 5. Litter characteristics in offspring from dams fed CON or HSF diet 
 Maternal CON Maternal HSF p Values 
Litter size 15 ± 1 14 ± 1 0.598 
 
Litter weight (g) 
Postnatal day 3 
Postnatal day 12 
133 ± 4 
386 ± 6 
136 ± 10 
438 ± 14 
0.797 
<0.001 
Weaning weight  52 ± 2 63 ± 2 < 0.001 
Values are expressed as mean ± SEM, n = 15 and n = 14 for offspring from dams fed CON or HSF diet, n = 
9 for comparisons of weaning weight. 
 
7.2. Effect of high saturated fat feeding in dams 
7.2.1. Pregnancy 
 There were no differences in the number of females that became pregnant 
between diet groups. Nine out of 12 dams fed HSF and 9 out of 11 dams that were fed 
CON diet became pregnant.  
 
7.2.2. Food intake and body weight of dams 
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Table 6. Fat pad mass, plasma hormones, and bone mineral and strength in dams 
   Values are expressed as mean ± SEM (n = 9 per group). BD, values below the level of detection,  
   no comparison made. 
 
Outcomes CON HSF p Value 
Body weight (g) 324 ± 5 350 ± 10 0.028 
 
Fat pad mass  
   
Retroperitoneal (g) 4.93 ± 0.41 6.18 ± 0.60 0.104 
(g/kg body weight) 15.24 ± 1.29 17.50 ± 1.34 0.244 
Omental (g) 4.30 ± 0.35 5.47 ± 0.45 0.055 
(g/kg body weight) 13.51 ± 1.20 15.61 ± 1.08 0.212 
Parametrial (g) 6.01 ± 0.48 8.0 ± 0.90 0.068 
(g/kg body weight) 18.59 ± 1.50 22.69 ± 2.26 0.150 
Total (g) 15.24 ± 1.03 19.65 ± 1.86 0.055 
(g/kg body weight) 47.18 ± 3.38 55.80 ± 4.42 0.141 
 
Plasma Hormones 
   
Leptin (pg/mL) 1357.7 ± 158.5 1936.8 ± 331.8 0.135 
TNF-α (pg/mL) BD BD  
IL-6 (pg/mL) 227.7 ± 63.1 506.3 ± 122.4 0.130 
MCP-1 (pg/mL) 391.2 ± 122.8 475.2 ± 124.9 0.525 
17β-estradiol (ng/mL) 0.03 ± 0.01 0.04 ± 0.01 0.485 
Progesterone (ng/mL) 21.5 ± 3.4 29.4 ± 3.2 0.110 
 
Bone Mineral 
   
Whole femur    
BMC (mg) 355.9 ± 15.4 367.0 ± 13.4 0.584 
BMD (mg/mm
2
) 1.70 ± 0.05 1.76 ± 0.04 0.379 
1/3 Proximal femur    
BMC (mg) 122.0 ± 6.2 123.9 ± 4.6 0.800 
BMD (mg/mm
2
) 1.62 ± 0.05 1.69 ± 0.05 0.332 
LV1-3    
BMC (mg) 244.5 ± 15.6 249.5 ± 11.5 0.792 
BMD (mg/mm
2
) 1.45 ± 0.05 1.48 ± 0.04 0.625 
 
Bone Strength 
   
Femur midpoint    
Peak load (N) 125.4 ± 9.1 138.3 ± 7.1 0.948 
Femur neck    
Peak load (N) 82.9 ± 17.4 62.3 ± 8.2 0.300 
LV3    
Peak load (N) 188.2 ± 18.4 220.4 ± 17.2 0.219 
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There were no differences in body weight between rats assigned to HSF or CON 
upon randomization. There was an interaction of maternal diet and time (weeks), while 
comparing food intake (kcal consumed per rat per day) in dams. Dams fed a HSF diet 
consumed more energy per day in 8 of 10 weeks (p < 0.05) compared to dams fed CON 
diet, with no differences at week 5 (p = 0.637) and week 8 (p = 0.096). Food intake was 
not measured during breeding or pregnancy and lactation, to avoid inconsistencies in 
food measurement with the presence of a male rat, and to reduce cage disruptions. There 
were no differences in body weight over 10 weeks of feeding prior to breeding, or at time 
of breeding. However, dams fed a HSF diet were heavier at necropsy than dams fed CON 
diet (Table 6).  
 
7.2.3. Fat pad masses of dams 
No differences were detected when comparing individual (retroperitoneal, 
omental, parametrial) and total fat pad weights. There were no additional differences in 
fat pad mass when adjusted for body weight (Table 6).  
 
7.2.4. Plasma hormones of dams 
 No differences were detected in plasma concentrations of leptin, IL-6, MCP-1,  
17β-estradiol and progesterone between dams fed HSF versus CON diet (Table 6). Levels 
of plasma TNF- α for some rats were below the minimum level of detection for the assay,  
therefore no comparison was made for plasma TNF-α. However, there was a greater 
number of dams fed HSF diet (n = 5) with detectable levels of TNF-α compared to dams 
fed CON diet (n = 2) (Table 6). 
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Figure 3. Percent mole fractions of fatty acids in femurs of dams: a) total SFAs, b) total 
MUFAs, and c) total PUFAs. Values are expressed as mean ± SEM. n = 7 or 8/group. * 
Values are significantly different from maternal CON (p < 0.05). CON: control diet; 
HSF: high ssaturated fat diet; SFAs: saturates; MUFAs: monounsaturates; PUFAs, 
polyunsaturates.  
 
* 
* 
3a) 
3b) 
3c) 
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Figure 4. Percent mole fractions of PUFAs in femurs of dams: a) total n3 PUFAs and b) 
total n6 PUFAs. Values are expressed as mean ± SEM. n = 7 or 8/group. * Values are 
significantly different from maternal CON (p < 0.05). CON: control diet; HFS: high 
saturated fat diet; PUFAs: polyunsaturates. 
 
7.2.5. Bone mineral and strength in femurs and lumbar vertebrae of dams 
 There were no differences in BMC and BMD of the whole femur and the 1/3
rd
 
proximal femur, as well as no differences in LV1-3 in dams fed HSF versus CON diet. 
Furthermore, no differences were detected in peak load of the femur midpoint, femur 
neck, or LV3 (Table 6). 
* 
* 
4a) 
4b) 
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7.2.6. Fatty acid composition of femurs of dams 
 Dams fed a HSF diet had greater percent mole fractions of total MUFAs and total 
PUFAs than dams fed CON diet (p < 0.001) (Figure 3). The greater percent mole 
fractions of total PUFAs corresponded with significant increases in n3 and n6 PUFAs (p 
< 0.001) (Figure 4). However there were no differences in total SFA content between 
dams fed HSF versus CON diet (p < 0.001) (Figure 3).  
 
7.3. Effect of maternal high fat diet on female offspring 
7.3.1. Food intake and body weight of female offspring 
There was an interaction between maternal diet and offspring age when 
comparing energy intake in growing female offspring, which represented increased 
energy consumption to support growth and development with age. All female offspring 
consumed more energy in later weeks of feeding (6
th
 and 8
th
 week of feeding), compared 
to earlier weeks of feeding (2
nd
 and 4
th
 week of feeding in offspring from dams fed HSF 
diet [p < 0.05]; 2
nd
 week of feeding in offspring from dams fed CON diet [p < 0.05]), 
regardless of maternal diet. There were no differences in body weight in growing female 
offspring over the duration of the feeding period (p = NS) (Figure 5).  
 
7.3.2. Fat pad masses of female offspring 
There were significant main effects for offspring age when examining 
retroperitoneal and omental fat pad weights, both absolute weights and weights relative to 
body weight (g/kg). Female offspring at 3 months of age had higher absolute and relative 
levels of retroperitoneal (p < 0.001) and omental (p < 0.001) fat pad masses compared to  
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Figure 5. a) Energy consumption and b) body weight of female offspring. Values are 
expressed as mean ± SEM.  
 
5a) 
5b) 
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at weaning. No comparisons were made for weanling parametrial fat pads as offspring 
have not reached reproductive maturity and negligible amounts of adipose tissue are 
stored in this depot (Table 7). 
 
7.3.3. Plasma hormones of female offspring 
 There was a significant interaction of maternal diet and age while comparing 
plasma MCP-1 concentrations (p = 0.026) in female offspring (Table 7). At weaning, 
females from dams fed HSF diet had higher concentrations of MCP-1 than females from 
dams fed CON diet. Additionally at 3 months of age, females from dams fed HSF diet 
had higher concentrations of MCP-1 than at weaning. There were no differences in 
plasma leptin, IL-6, 17β-estradiol or progesterone in female offspring at weaning or 3 
months of age (p = NS). Plasma concentrations of TNF-α were below the minimum level 
of detection for the assay, therefore no comparison was made (Table 7). However at 
weaning, a greater number of females from dams fed HSF diet (n = 3) had detectable 
levels of TNF-α than females from dams fed CON diet (n = 0).  
 
7.3.4. Body composition of female offspring 
There were significant interactions of maternal diet and age for % lean mass (p = 
0.013), % fat mass (p = 0.014), and % bone mass (p = 0.001) in female offspring at 
weaning and 3 months of age (Figure 6). At weaning, females from dams fed HSF diet 
had lower % lean mass, with higher % fat and % bone mass than offspring from dams fed 
CON diet (Figure 6). Female offspring from dams fed CON diet at 3 months of age had 
lower % lean mass, and higher fat and % bone mass than at weaning. Moreover, females  
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Figure 6. Body composition of female offspring, expressed as a percent of ROI: a) lean 
mass, b) fat mass, and c) bone mass. Values are expressed as mean ± SEM. Weanling 
offspring, n = 7/group; 3 month offspring, n = 9/group. * Values are significantly 
different from maternal CON at weaning (p < 0.05). CON: control diet; HSF: high 
saturated fat diet; ROI: region of interest.  
 
6a) 
6b) 
6c) 
* 
* 
* 
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Figure 7. Bone mineral content (mg) of female offspring: a) whole femur, b) 1/3 
proximal femur, and c) LV1-LV3. Values are expressed as mean ± SEM. Weanling 
offspring, n = 7/group; 3 month offspring, n = 9/group. BMC: bone mineral content; 
CON: control diet; HSF: high saturated fat diet; LV1-LV3: lumbar vertebrae 1-3.  
 
 
7a) 
7b) 
7c) 
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Figure 8. Peak load (N) of female offspring: a) femur midpoint, b) femur neck, c) LV3. 
Values are expressed as mean ± SEM. n = 9/group, except LV3 peak load (n = 7/group as 
vertebral strength of 2 samples per group exceeded the load cell capacity of 475N). CON: 
control diet; HSF: high saturated fat diet; LV3: lumbar vertebrae 3. 
 
8a) 
8b) 
8c) 
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from dams fed HSF diet at 3 months of age had lower % bone mass than at weaning 
(Figure 5). 
 
7.3.5. Bone mineral and strength in femurs and lumbar vertebrae of female offspring 
There was a significant interaction of maternal diet and age for whole femur 
BMD (p = 0.040) (Figure 7). At weaning, females from dams fed HSF diet had greater 
BMD in the whole femur than females from dams fed CON diet. Females from dams fed 
CON diet at 3 months of age had greater whole femur BMD than at weaning. Similarly, 
females from dams fed HSF diet at 3 months of age had greater whole femur BMD than 
at weaning. There were main effects of age for BMC and BMD at all bone sites. Females 
at 3 months of age had higher BMC (p < 0.001) (Figure 6) and BMD (p < 0.001) (Figure 
7) than females at weaning, regardless of maternal diet, due to growth. No differences 
were detected between groups in peak load at the femur midpoint (p = 0.114), femur 
neck (p = 0.600), or LV3 (p = 0.523) in female offspring at 3 months of age (Figure 8).  
 
7.3.6. Fatty acid composition of femurs from female offspring 
 There were significant interactions for maternal diet and age while examining 
percent mole fractions of total SFAs (p = 0.009), MUFAs (p < 0.001), PUFAs (p = 0.002) 
(Figure 9) and n6 PUFAs (p < 0.001) (Figure 10) in femurs of female offspring. At 
weaning, females from dams fed HSF diet had higher total MUFAs, with lower total 
PUFAs and n6 PUFAs. Females from dams fed CON diet at 3 months of age had lower 
total SFAs, and higher total MUFAs, total PUFAs, and n6 PUFAs than at weaning. 
Similarly, females from dams fed HSF diet at 3 months of age had lower total SFAs and 
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Figure 9. Percent mole fractions of fatty acids in femurs from female offspring: a) total 
SFAs, b) total MUFAs, and c) total PUFAs. Values are expressed as mean ± SEM. n = 8-
9/group, * Values are significantly different from maternal CON at weaning (p < 0.05). 
** Values are significantly different from maternal CON at 3 months (p < 0.05). CON: 
control diet; HSF: high ssaturated fat diet; SFAs: saturates; MUFAs: monounsaturates; 
PUFAs, polyunsaturates. 
9a) 
9b) 
9c) 
** 
** 
* 
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Figure 10. Percent mole fractions of PUFAs in femurs from female offspring: a) total n3, 
and b) total n6. Values are expressed as mean ± SEM. n = 8-9/group. * Values are 
significantly different from maternal CON at weaning (p < 0.05). ** Values are 
significantly different from maternal CON at 3 months (p < 0.05). CON: control diet; 
HSF: high ssaturated fat diet; PUFAs, polyunsaturates. 
 
 
total MUFAs, with higher total and n6 PUFAs than at weaning. At 3 months of age, 
females from dams fed HSF diet had higher total SFAs, with lower total (Figure 9) and 
n6 PUFAs (Figure 10). 
10a) 
10b) 
* 
** 
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Chapter 8.0: Discussion 
 The results of this study demonstrate that female Wistar rat offspring body 
composition and bone health are not negatively impacted by a single generation of 
maternal consumption of a HSF diet. Differences in body composition and bone health at 
weaning were not sustained at 3 months of age; therefore the elevated level of fat in the 
maternal dietary intervention did not contribute to long-lasting programming effects in 
female offspring. Alterations in femur fatty acid composition due to maternal 
consumption of a HSF diet persisted to 3 months of age. Further study is required to 
determine if and when fatty acid composition of the femur reflects the diet consumed. 
Despite the persistent changes in femur fatty acid composition, there were no differences 
in femoral and lumbar vertebrae peak load in female from mothers fed a HSF diet at 3 
months of age suggesting that fatty acid composition of bone may not be directly 
associated with bone strength.  
 
8.1. Female offspring 
8.1.1. Food intake, body weight, and fat pad masses 
 Differences in food intake in female offspring were apparent at 4, 6 and 8 weeks 
of feeding post-weaning, regardless of maternal diet. In both groups of offspring, post-
weaning energy consumption was higher at weeks 4, 6 and 8 of feeding compared to 
week 2. This may be an effect of growth and development, where offspring need to 
consume more food to support rapid growth during this time. This finding is also in 
accordance with the female offspring body weight. Although weanling females from 
dams fed the HSF diet were heavier than those from dams fed CON diet, these 
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differences were diminished over the feeding period. Similarly, there were significant 
differences in fat pad mass, in absolute values and adjusted for body weight, between all 
offspring at 3 months of age compared to weaning. However this was only an effect of 
offspring age and growth, and not necessarily maternal diet. It may be that weanling 
females from mothers fed the high fat diet were heavier with greater fat mass than 
females from mothers fed CON diet due to the greater availability of nutrients from 
mother’s milk during suckling. It is speculated that the milk from mothers fed the HSF 
diet would have contained more total energy compared to milk from mothers fed control 
diet, with a higher level of fat, protein, and other important nutrients [17, 18]. Therefore, 
exposure to mother’s milk during suckling in females from mothers fed the HSF diet may 
have contributed to greater weight gain and level of fat mass.   
 
8.1.2. Body composition 
Body composition of female offspring was also impacted by the maternal HSF 
diet at weaning. Weanling females from dams fed a high fat diet had lower % lean mass, 
and higher % fat and % bone mass than females from dams fed CON diet. The findings 
for % lean mass and % fat mass are consistent with current literature [17, 150]. This is 
the first study to report % bone mass in weanling female offspring as a result of a 
maternal HSF diet. Higher % bone mass in weanling females from dams fed HSF diet 
may be due to greater nutrient availability provided in mother’s milk during suckling, as 
offspring are consuming a diet similar in composition to the diet of the mother. This has 
been demonstrated in previous studies that have shown the composition of mother’s milk 
reflects the diet consumed [17, 18], and therefore may contribute to greater availability of 
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nutrients involved in bone mineral acquisition such as calcium and vitamin D. Despite 
these findings, observed differences in body composition between groups at weaning 
were not sustained at 3 months of age, indicating the maternal high fat diet did not 
contribute to long-lasting changes in female offspring body composition. Differences 
observed at weaning may be attributed to the greater availability of nutrients provided in 
the dam’s milk (i.e. increased fat and protein [17, 18]). Any effects observed at 3 months 
of age may have been attributed to growth and development. Females from dams fed 
CON diet at 3 months of age had lower % lean mass, with higher % fat and % bone mass 
than at weaning. Additionally, 3 month old females from dams fed HSF diet had lower % 
bone mass than at weaning. These apparent findings cannot be attributed to maternal diet, 
but rather offspring growth and development. 
 
8.1.3. Plasma hormone concentrations 
 Maternal high fat diet consumption influenced plasma levels of MCP-1 at 
weaning, where females from dams fed HSF diet had higher levels than females from 
dams fed CON diet. This elevation in MCP-1 however, did not persist at 3 months of age 
in females from dams fed HSF diet, as levels were significantly lower than MCP-1 levels 
in offspring at weaning. Therefore there was no programming effect on MCP-1 levels due 
to maternal consumption of a HSF diet. Differences in weanling MCP-1 plasma levels 
may be attributed to the higher fat content in mother’s milk during suckling. These results 
are also in accordance with body composition at weaning, where females from dams fed 
HSF diet had greater % fat mass, as levels of MCP-1 are positively correlated with 
overall fat mass [192]. Furthermore, the finding that MCP-1 levels are lower at 3 months 
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of age than at weaning in females from dams fed HSF diet is also in accordance with 
adiposity, where elevations in % fat mass at weaning did not persist to early adulthood. 
 
8.1.4. Bone mineral, strength, and fatty acid composition 
 Femoral bone mineral and fatty acid profile in females at weaning and 3 months 
were also impacted by maternal HSF diet. The finding that whole femur BMD in 
weanlings from dams fed HSF diet was greater than females from dams fed CON may 
also be attributed to greater nutrient availability from mother’s milk during suckling, 
allowing for greater bone mineral acquisition. Interestingly, this effect was only found in 
BMD of the whole femur. However there was no programming effect of maternal HSF 
diet on offspring whole femur BMD as these differences were not sustained at 3 months 
of age. Fatty acid composition of femurs at weaning reflected the fatty acid composition 
of the diet consumed, which is in agreement with previous studies in older rats where 
dietary fat has been manipulated [63, 190]. Furthermore, it is established that different 
skeletal sites, such as the femur and lumbar vertebrae, respond similarly to variations in 
dietary fatty acid composition [190, 193, 194]. Interestingly, changes in femur fatty acid 
composition at weaning were sustained at 3 months of age, with additional elevations in 
SFAs as well. Regardless of these findings, there were no functional differences in 
femoral bone strength, suggesting that increased total SFA content may not contribute to 
increased fracture risk at early adulthood. It may also be that changes in bone fatty acid 
composition may not necessarily be detrimental to bone health, and may not lead to 
changes in bone strength. However this is speculative and further research in this area is 
needed. 
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 Typically, bone health is a measure of bone quantity (mineral), quality 
(microarchitecture) and strength. However for the purpose of this study, we did not 
measure bone quality. We measured bone strength, a predictor of fracture, after 
measuring bone mineral, to understand whether there were functional differences that 
rendered the bones weaker and/or stronger due to maternal consumption of a HSF diet. 
Since both bone quantity and quality are predictors of bone strength, we were able to 
appropriately determine that there was no evidence of programming, as there were no 
differences in quantity or strength. 
 
8.2. Dams 
8.2.1. Pregnancy outcomes and litter characteristics 
 Many of the outcomes measured in female offspring were also measured in dams, 
to appropriately determine the extent to which dam body weight and overall bone health 
impacted offspring health. It is well established that a maternal HSF diet can impact 
fertility and has been shown to result in unsuccessful pregnancies in rodents [195]. In this 
study, only 3 dams fed the HSF diet and 2 dams fed CON diet did not get pregnant, 
therefore a maternal high fat diet did not negatively impact fertility in dams over the 
studied term. This finding was also shown in other studies using rodents that 
implemented lard as the primary fat source in the HSF diet [196]. A maternal HSF diet 
did not impact male:female ratio and litter size, which has been shown previously [17, 
196, 197]. Significant differences in litter weight were apparent at PND12, which was 
likely the result of greater nutrient delivery from mother’s milk. Differences in litter 
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weight were sustained at weaning [44, 197], which may have been due to greater nutrient 
delivery from mother’s milk and possible consumption of mother’s diet.  
 
8.2.2. Food intake, body weight, fat pad masses, and plasma hormone concentrations 
Dams fed the HSF diet had greater energy consumption in 8 of 10 weeks of 
feeding compared to dams fed CON diet. Dams fed the HSF diet may have compensated 
food intake for the increased energy content of the diet, as they consumed less food 
(grams per rat per day) than dams fed CON for 6 of 10 weeks. This may have contributed 
to the lack of obesity found in dams as they were able to self-regulate food intake.  
In addition to a lack of obesity, there were no differences in body weight for 10 
weeks of feeding before breeding, however dams that consumed HSF diet seemed to gain 
more weight during gestation and lactation as body weight at necropsy was significantly 
higher, as shown previously [150], but were not obese. Recent studies in rodents have 
speculated that maternal obesity rather than diet is the key factor for inducing 
programming in offspring [198]. With this in mind, the lack of maternal obesity in this 
study may have contributed to the absence of programming in female offspring body 
composition and bone health. The lack of significance in fat pad masses (absolute and 
adjusted for body weight) and plasma hormones are in accordance with body weight and 
food intake data.  
 
8.2.3. Bone mineral, strength, and fatty acid composition 
As hypothesized, the fatty acid composition of femurs reflected that of the diet 
consumed with greater SFA content. Although previous studies have shown that a high 
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fat diet can lower BMC, BMD [70], structure [43] and even strength in rodents [66], there 
were no differences in bone mineral (BMC, BMD) and strength in femurs and lumbar 
vertebrae. Therefore higher SFA content in femurs does not contribute to functional 
differences in bone strength. Whether higher SFA content can alter bone structure in 
dams and offspring remains to be determined.  
 
Chapter 9.0: Conclusions 
 A maternal HSF diet modified with higher levels of protein, vitamins, and 
minerals, does not elicit long-term changes in female offspring body composition 
(increased fat mass, lower lean and bone mass) or bone health (lower bone mineral and 
peak load) at 3 months of age. Although female offspring at weaning from mothers fed 
the HSF diet had higher fat mass and bone mass, with lower lean mass compared to 
female offspring from mothers fed CON diet, this did not persist to 3 months of age. 
Furthermore, fat pad masses were not different in offspring at weaning and 3 months of 
age. There were no differences in BMC in the femur or lumbar vertebrae, however 
females from mothers fed the HSF diet had higher femoral BMD at weaning, but not 3 
months of age. Femur fatty acid composition of weanling female offspring from mothers 
fed a HSF diet reflected maternal diet (higher total MUFAs, lower total and n6 PUFAs) 
from exposure during suckling. However these alterations in femur fatty acid 
composition (lower total and n6 PUFAs) were persistent at 3 months of age, with 
additional increases in higher SFA content. We speculate this may not be a true effect of 
programming; rather females are still growing at 3 months of age and may use these fat 
stores to support further bone growth. Even considering these consistent alterations in 
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femur fatty acid composition, there were no differences in femoral strength, or vertebral 
strength. Therefore, although exposure to the HSF diet during suckling did promote 
changes in body composition and bone health at weaning, it appears there was no 
programming, as these effects were not observed at 3 months of age. This is an indication 
that a healthy post-weaning diet may prevent prolonged effects of maternal HSF diet 
consumption on female offspring body composition and bone health. 
 
9.1. Strengths 
 There are many unique aspects of this research that allowed us to determine 
whether maternal HSF diet consumption was a major contributor to changes in female 
offspring body composition and bone health. This has been the only research to examine 
female offspring at two different life stages, early life (weaning) and young adulthood (3 
months of age). Although one study has examined female offspring at two time points, 
3.5 and 6.5 months of age [152], this does not represent two unique life stages, as 
offspring are in adulthood at both time points. We believe it is important to study 
offspring at early life and early adulthood, as these two life stages represent two different 
rates of growth, fast (early life) and slow (early adulthood).  
 A major strength of this study was that the level of protein, vitamins, and minerals 
were increased in the HSF diet. To reiterate, this was done to compensate for the 
increased energy in the diet provided by the greater level of fat. This compensation, or 
nutrient adjustment, kept the relative energy contribution of these important nutrients 
similar to that of a healthy diet. Overall, this ensured that any observed effect on female 
offspring body composition and bone health was truly attributed to maternal HSF diet 
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consumption, and not due to lower intake of these nutrients on an energy basis. This is 
especially important as the consumption of protein, vitamins (e.g. vitamin D), and 
minerals (e.g. calcium) are essential for optimal bone health [69, 153, 174, 177, 199]. 
Although one study did also increase the level of protein, vitamins, and minerals in the 
high fat diet [58], there was no dietary control group in which the results could be 
appropriately attributed to maternal high fat diet consumption (i.e. female offspring from 
mothers fed a high fat diet were also fed the high fat diet). In addition to the adjustment 
of important nutrients, we had dietary interventions that allowed us to tease out the true 
effect of maternal HSF diet consumption (i.e. female offspring from mothers fed a HSF 
diet were fed a healthy control diet). 
 This research is also novel in that it examined the impact of maternal HSF diet 
consumption on female offspring body composition and bone health. Most studies have 
investigated either body composition [17, 44, 149, 151] or bone health [58] in female 
offspring. Investigating both female offspring body composition and bone health 
provides a greater understanding of the health status of female offspring as a whole, 
rather than specific to certain tissue. Moreover, this research is the first to investigate 
fatty acid composition in female offspring bones as a result of maternal HSF diet. With 
this novel information, we were able to determine that although there may have been 
changes in fatty acid composition that were persistent at 3 months of age, this did not 
translate into functional differences in strength. 
 
9.2. Limitations 
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 The current study had a few limitations that should be taken into consideration. 
Firstly, although we observed changes in female offspring body composition at weaning, 
we did not examine the composition of mother’s milk. Knowing the nutrient content in 
terms of macronutrients, vitamins, and minerals may have helped to understand the 
underlying changes in female offspring body composition and BMD at weaning. 
Secondly, markers of bone formation and bone resorption were not examined in addition 
to measurements of bone mineral and strength. These markers could help determine 
whether the increased femoral BMD in weanling female offspring was due to the up-
regulation of bone formation, or a result of nutrient delivery.  
 
9.3. Future Implications 
 Based on the conclusions of this study, it seems that a healthy diet post-weaning 
may prevent long-lasting changes in body composition and bone health in female 
offspring, despite being born to mothers fed a HSF diet. This research will provide 
further insight to the impact of maternal HSF diet consumption on female offspring at 
weaning and adulthood, which is important considering the numerous discrepancies in 
the literature. Long-term, the findings from this study may help to develop nutritional 
strategies and dietary recommendations for the general public. This research may also 
help parents promote healthy eating and overall optimal health in their children. 
 
9.4. Future Research 
Future research in the area of offspring health due to maternal HSF diet 
consumption should continue, considering the high incidence of obesity and osteoporosis 
  
95 
 
in Canada [1, 200]. To have a greater understanding of female offspring body 
composition and bone health due to maternal diet, future investigations should consider 
the following: 
i. Investigation of bone microarchitecture using micro-computed tomography. Bone 
strength measurements in weanling offspring were difficult to obtain in this study, as 
femurs were still immature. Future investigation of bone architecture would provide 
additional information on the impact of maternal HSF diet consumption on bone health, 
in addition to measurements of bone mineral. Further research is required to determine 
whether bone microarchitecture is altered as a result of maternal HSF diet consumption. 
Although some studies have investigated bone microarchitecture in female offspring at 
multiple sites, these studies did not have: 1) experimental groups designed to ensure that 
observed effects were truly attributed to maternal diet (i.e. offspring from mothers fed a 
high fat diet were also fed a high fat diet post-weaning) [58]; and 2) increased the level of 
protein, vitamins and minerals to account for the increased energy provided by the 
elevated fat in the diet [152]. Determination of bone microarchitecture at multiple sights, 
with study designs that include both factors listed above, will allow for a greater 
understanding of the impact of maternal HSF diet consumption on female offspring bone 
structure.  
ii. Mechanisms underlying changes in bone growth. Future studies in this area of research 
could investigate specific changes in bone development by measuring transcription 
factors governing bone growth and differentiation (i.e. Runx2, osterix). This would help 
determine whether increases in bone mineral, as determined in this study (in weanlings 
from mothers fed a high fat diet), are attributed to greater nutrient availability from 
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mother’s milk, or due to upregulation of these transcription factors that promote bone 
formation. 
iii. Storage location of altered bone fatty acids. Considering that this study showed 
persistent alterations in bone fatty acid composition in offspring at early adulthood 
without changes in bone strength, it is important to understand the underlying 
mechanisms. Although there is evidence of changes in total bone fatty acid composition, 
it is unclear where these lipids are stored and where these alterations have occurred. No 
study has yet to investigate the location of storage of these fatty acids in bone. Perhaps 
details into lipid storage in bone will help determine the underlying reason why changes 
in bone fatty acid composition do not translate into differences in bone strength. 
iv. Paternal consumption of a HSF diet. It may also be important to determine whether 
there is a paternal influence, in addition to maternal, on programming of female offspring 
body composition and bone health. This is important considering the increased 
prevalence of obesity in Canadian men [200]. Furthermore, recent evidence shows that 
paternal consumption of a high fat diet can predispose offspring to become obese in 
adulthood, which may have been facilitated by epigenetic changes [201]. Therefore, it 
may be important to determine the direct impact of paternal HSF diet consumption on 
female offspring body composition and bone health, and whether these effects are further 
exacerbated when mothers also consume a HSF diet. 
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